image_name
stringlengths 68
68
| type
stringclasses 2
values | gt_table
stringlengths 116
12.6k
|
|---|---|---|
f42efd1f5c2a195f969b0fddc6cbb36476c0b8fff997b72374becefaf5c59cb1.png | simple | <table><tr><td>Independent variables</td><td>Unadjusted Rate Ratio (95 % CI)<sup>a</sup></td><td><i>P</i> value</td><td>Adjusted Rate Ratio (95 % CI)<sup>b</sup></td><td><i>P</i> value</td></tr><tr><td>Age at each pre-recruitment year (per year)</td><td>1.0 (1.0. 1.0)</td><td>0.048</td><td>1.0 (1.0, 1.0)</td><td>0.012</td></tr><tr><td>Time (per year)</td><td>1.2 (1.1. 1.2)</td><td><0.001</td><td>1.1 (1.0, 1.1)</td><td><0.001</td></tr><tr><td>Female gender</td><td>1.1 (0.9, 1.5)</td><td>0.349</td><td>1.0 (0.8, 1.2)</td><td>0.813</td></tr><tr><td>Aboriginals (yes vs. no)</td><td>0.9 (0.7, 1.3)</td><td>0.635</td><td>1.1 (0.8, 1.4)</td><td>0.617</td></tr><tr><td>White (yes vs. no)</td><td>1.1 (0.8, 1.4)</td><td>0.594</td><td>0.9 (0.7, 1.1)</td><td>0.217</td></tr><tr><td>Schizophrenia (yes vs. no)</td><td>7.7 (6.4, 9.3)</td><td><0.001</td><td>4.7 (3.9, 5.6)</td><td><0.001</td></tr><tr><td>Bipolar disorder (yes vs. no)</td><td>5.7 (4.6, 7.0)</td><td><0.001</td><td>2.2 (1.8, 2.6)</td><td><0.001</td></tr><tr><td>Personality disorder (yes vs. no)</td><td>3.0 (2.3, 3.9)</td><td><0.001</td><td>1.6 (1.8, 2.6)</td><td><0.001</td></tr><tr><td>Depressive disorder (yes vs. no)</td><td>3.2 (2.7, 3.8)</td><td><0.001</td><td>1.6 (1.3, 1.9)</td><td><0.001</td></tr><tr><td>Anxiety-neurotic disorder (yes vs. no)</td><td>2.8 (2.3, 3.5)</td><td><0.001</td><td>1.5 (1.2, 1.8)</td><td><0.001</td></tr><tr><td>Alcohol dependence (yes vs. no)</td><td>2.5 (1.9, 3.2)</td><td><0.001</td><td>1.5 (1.2, 2.0)</td><td>0.001</td></tr><tr><td>Drug dependence (yes vs. no)</td><td>2.4 (2.0, 2.9)</td><td><0.001</td><td>1.5 (1.2, 1.7)</td><td><0.001</td></tr><tr><td>Non-psychiatric service utilization<sup>c</sup></td><td></td><td></td><td></td><td></td></tr><tr><td> High (≥32)</td><td>3.4 (2.7, 4.3)</td><td><0.001</td><td>2.3 (1.9, 2.8)</td><td><0.001</td></tr><tr><td> Medium (16 to 31)</td><td>2.1 (1.7, 2.7)</td><td><0.001</td><td>1.5 (1.2, 1.8)</td><td><0.001</td></tr><tr><td> Low (≤15)</td><td>Reference</td><td>-</td><td>Reference</td><td>-</td></tr></table> |
44e3d14b7dfe551c2e91a47032655e772af37d9ab904d7c8e3988f9e978120a1.png | simple | <table><tr><td>Patients with:</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>2 positive Criteria</td><td></td><td>Crit1+</td><td>Crit2+</td><td>Crit3+</td><td>Crit4+</td><td></td></tr><tr><td></td><td>Crit2+</td><td>11</td><td></td><td></td><td></td><td></td></tr><tr><td></td><td>Crit3+</td><td>75</td><td>36</td><td></td><td></td><td></td></tr><tr><td></td><td>Crit4+</td><td>10</td><td>7</td><td>19</td><td></td><td></td></tr><tr><td></td><td>Crit5+</td><td>9</td><td>2</td><td>4</td><td>4</td><td></td></tr><tr><td>3 positive Criteria</td><td></td><td>Crit12+</td><td>Crit13+</td><td>Crit14+</td><td>Crit23+</td><td>Crit24+</td></tr><tr><td></td><td>Crit3+</td><td>109</td><td></td><td></td><td></td><td></td></tr><tr><td></td><td>Crit4+</td><td>4</td><td>39</td><td></td><td>10</td><td></td></tr><tr><td></td><td>Crit5+</td><td>9</td><td>78</td><td>5</td><td>5</td><td>8</td></tr><tr><td>4 positive Criteria</td><td>Crit1234+</td><td>Crit1235+</td><td>Crit1245+</td><td>Crit1345+</td><td>Crit2345+</td><td></td></tr><tr><td></td><td>22</td><td>37</td><td>9</td><td>63</td><td>0</td><td></td></tr><tr><td>5 positive Criteria</td><td>Crit12345+</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td></td><td>35</td><td></td><td></td><td></td><td></td><td></td></tr></table> |
a4ae770883c536a12879ad6bac064404d1b5e09eeb6e33240e117e1dc4c35309.png | simple | <table><tr><td>No.</td><td>Group</td><td>Treatment</td><td>Radiation<sup>a</sup></td><td>Microgravity</td></tr><tr><td>1</td><td>Spaceflight</td><td>Spaceflight static slot</td><td>1.92 mGy</td><td>μg</td></tr><tr><td>2</td><td>Spaceflight control</td><td>Spaceflight 1g-centrifuge slot</td><td>2.27 mGy</td><td>1g</td></tr><tr><td>3</td><td>Ground control</td><td>Ground static slot</td><td>–</td><td>1g</td></tr></table> |
cd1f5a2b88d315a0ebd6ae58d38461ffd11f10ed061b5bf7c62376b75ce4ee08.png | simple | <table><tr><td>Haplogroup</td><td>Gene vs Geography</td><td>p</td><td>Gene vs Language</td><td>p</td></tr><tr><td>R5</td><td>0.1276</td><td>0.0475</td><td>0.1748</td><td>0.2</td></tr><tr><td>R6</td><td>0.2654</td><td>0.037</td><td>0.13248</td><td>0.19</td></tr><tr><td>R7</td><td>0.299</td><td>0.023</td><td>0.219</td><td>0.225</td></tr><tr><td>R8</td><td>0.211496</td><td>0.01753</td><td>0.23248</td><td>0.31</td></tr><tr><td>R30</td><td>0.189917</td><td>0.127</td><td>0.1348</td><td>0.28</td></tr><tr><td>R31</td><td>0.172</td><td>0.1873</td><td>0.141</td><td>0.25</td></tr></table> |
9e8c2baf82b32d805fe7858474744954e8e686f2af7b7084177e841e82361f17.png | complex | <table><tr><td>Characteristics</td><td>Variables</td><td>AMA (%)</td><td>STMA (%)</td></tr><tr><td rowspan="2">Gender</td><td>Male</td><td>27</td><td>26</td></tr><tr><td>Female</td><td>23</td><td>24</td></tr><tr><td rowspan="6">Marital status</td><td>Single (never married)</td><td>6.1</td><td>2.7</td></tr><tr><td>Married</td><td>32.7</td><td>40.1</td></tr><tr><td>Cohabitation</td><td>2</td><td>2</td></tr><tr><td>Separated</td><td>1.4</td><td>2.7</td></tr><tr><td>Divorced</td><td>5.4</td><td>1.4</td></tr><tr><td>Widowed</td><td>3.4</td><td>0</td></tr><tr><td rowspan="4">Level of education</td><td>No education</td><td>15.4</td><td>12.8</td></tr><tr><td>Primary</td><td>16.8</td><td>15.4</td></tr><tr><td>Secondary</td><td>16.1</td><td>17.4</td></tr><tr><td>Tertiary</td><td>2</td><td>4</td></tr><tr><td rowspan="2">Employment</td><td>No</td><td>36.7</td><td>33.3</td></tr><tr><td>Yes</td><td>14.3</td><td>15.7</td></tr><tr><td rowspan="7">Age group</td><td>40–44</td><td>2</td><td>3.3</td></tr><tr><td>45–49</td><td>11</td><td>7.3</td></tr><tr><td>50–54</td><td>12</td><td>8</td></tr><tr><td>55–59</td><td>8.7</td><td>10.7</td></tr><tr><td>60–64</td><td>6</td><td>6.7</td></tr><tr><td>65–69</td><td>4</td><td>6</td></tr><tr><td>70+</td><td>6</td><td>8</td></tr><tr><td rowspan="8">Number of years living in the city (year group)</td><td>35–39</td><td>13.3</td><td>10.7</td></tr><tr><td>40–44</td><td>8</td><td>10</td></tr><tr><td>45–49</td><td>10.7</td><td>9.3</td></tr><tr><td>50–54</td><td>7.3</td><td>6</td></tr><tr><td>55–59</td><td>4.7</td><td>6</td></tr><tr><td>60–64</td><td>2</td><td>2.7</td></tr><tr><td>65–69</td><td>2</td><td>1.3</td></tr><tr><td>70+</td><td>2</td><td>4</td></tr><tr><td> </td><td><i>N</i> = 150</td><td> 75</td><td>75</td></tr></table> |
9e49a4fc88e3fe927254edf078c07094e1fee1adeccf29871a8957c013305904.png | complex | <table><tr><td></td><td colspan="4">Support Male Circumcision</td></tr><tr><td>Variables</td><td>Total (4, 874)</td><td>Yes (3,276)</td><td>No (1,598)</td><td><i>P</i>-values</td></tr><tr><td></td><td><i>n</i> (%)</td><td><i>n</i> (%)</td><td><i>n</i> (%)</td><td></td></tr><tr><td>Education</td><td></td><td></td><td></td><td></td></tr><tr><td> No education</td><td>892 (18.3)</td><td>431 (48.3)</td><td>461 (51.7)</td><td><0.0001</td></tr><tr><td> Primary</td><td>3125 (64.1)</td><td>2130 (68.2)</td><td>995 (31.8)</td><td></td></tr><tr><td> Secondary</td><td>710 (14.6)</td><td>592 (83.4)</td><td>118 (16.6)</td><td></td></tr><tr><td> Tertiary</td><td>147 (3.02)</td><td>123 (83.7)</td><td>24 (16.3)</td><td></td></tr><tr><td>Age groups</td><td></td><td></td><td></td><td></td></tr><tr><td> 15–24</td><td>1356 (27.8)</td><td>956 (70.5)</td><td>400 (29.5)</td><td><0.0001</td></tr><tr><td> 25–34</td><td>1819 (37.3)</td><td>1267 (69.7)</td><td>552 (30.4)</td><td></td></tr><tr><td> 35–44</td><td>1195 (24.5)</td><td>769 (64.4)</td><td>426 (35.7)</td><td></td></tr><tr><td> 45 and over</td><td>504 (10.3)</td><td>284 (56.4)</td><td>220 (43.7)</td><td></td></tr><tr><td>Wealth Index</td><td></td><td></td><td></td><td rowspan="2"><0.0001</td></tr><tr><td> Poorest</td><td>1032 (21.2)</td><td>511 (49.5)</td><td>521 (50.5)</td></tr><tr><td> Poorer</td><td>1113 (22.8)</td><td>674 (60.6)</td><td>439 (39.4)</td><td></td></tr><tr><td> Middle</td><td>985 (20.2)</td><td>682 (69.2)</td><td>303 (30.8)</td><td></td></tr><tr><td> Richer</td><td>878 (18.0)</td><td>660 (75.2)</td><td>218 (24.8)</td><td></td></tr><tr><td> Richest</td><td>866 (17.8)</td><td>749 (86.5)</td><td>117 (13.5)</td><td></td></tr><tr><td>Religion</td><td></td><td></td><td></td><td></td></tr><tr><td> Catholic</td><td>2093 (42.9)</td><td>1206 (57.6)</td><td>887 (42.4)</td><td><0.0001</td></tr><tr><td> Protestant</td><td>1572 (32.3)</td><td>1069 (68.0)</td><td>503 (32.0)</td><td></td></tr><tr><td> Pentecostal</td><td>396 (8.1)</td><td>263 (66.4)</td><td>133 (33.6)</td><td></td></tr><tr><td> Muslim</td><td>604 (12.4)</td><td>575 (95.2)</td><td>29 (4.8)</td><td></td></tr><tr><td> Other religion</td><td>209 (4.3)</td><td>163 (78.0)</td><td>46 (22.0)</td><td></td></tr><tr><td>Place of Residence</td><td></td><td></td><td></td><td></td></tr><tr><td> Urban</td><td>643 (13.2)</td><td>542 (84.3)</td><td>101 (15.7)</td><td><0.0001</td></tr><tr><td> Rural</td><td>4231 (86.8)</td><td>2734 (64.6)</td><td>1497 (35.4)</td><td></td></tr><tr><td>Access to Health facility</td><td></td><td></td><td></td><td></td></tr><tr><td> Yes</td><td>1788 (36.7)</td><td>1262 (70.6)</td><td>526 (29.4)</td><td><0.0001</td></tr><tr><td> No</td><td>3086 (63.3)</td><td>2014 (65.3)</td><td>1072 (34.7)</td><td></td></tr><tr><td>Ethnic groups</td><td></td><td></td><td></td><td></td></tr><tr><td> Baganda</td><td>596 (12.23)</td><td>523 (87.75)</td><td>73 (12.25)</td><td><0.0001</td></tr><tr><td> Banyankole</td><td>402 (8.25)</td><td>274 (68.16)</td><td>128 (31.84)</td><td></td></tr><tr><td> Basoga</td><td>481 (9.87)</td><td>464 (96.47)</td><td>17 (3.53)</td><td></td></tr><tr><td> Bakiga</td><td>266 (5.46)</td><td>155 (58.27)</td><td>111 (41.73)</td><td></td></tr><tr><td> Itesa</td><td>449 (9.21)</td><td>243 (54.12)</td><td>206 (45.88)</td><td></td></tr><tr><td> Other</td><td>2680 (54.99)</td><td>1,617 (60.34)</td><td>1,063 (39.66)</td><td></td></tr></table> |
6060467036f7461e8507cb16e6194eb1527887bf60429837c2cf25fbf6de1275.png | complex | <table><tr><td>Pollutants</td><td>No. of other sites</td><td>Median correlation (range)</td></tr><tr><td colspan="2">Fine particles and components</td></tr><tr><td>24-hr avg PM<sub>2.5</sub></td><td>12<sup><i>b</i></sup></td><td>0.88 (0.46–0.95)</td></tr><tr><td>24-hr avg PM<sub>2.5</sub></td><td>3<sup><i>c</i></sup></td><td>0.88 (0.76–0.95)</td></tr><tr><td>Major ions</td></tr><tr><td>24-hr avg SO<sub>4</sub><sup>2–</sup></td><td>3</td><td>0.90 (0.76–0.94)</td></tr><tr><td>24-hr avg NO<sub>3</sub><sup>–</sup></td><td>3</td><td>0.88 (0.75–0.90)</td></tr><tr><td>Carbon</td></tr><tr><td>24-hr avg OC</td><td>3</td><td>0.43 (0.38–0.69)</td></tr><tr><td>24-hr avg EC</td><td>3</td><td>0.47 (0.37–0.52)</td></tr><tr><td>Metals and metalloids</td></tr><tr><td>24-hr avg Si</td><td>3</td><td>0.96 (0.68–0.96)</td></tr><tr><td>24-hr avg K</td><td>3</td><td>0.71 (0.60–0.74)</td></tr><tr><td>24-hr avg Ca</td><td>3</td><td>0.35 (0.30–0.37)</td></tr><tr><td>24-hr avg Fe</td><td>3</td><td>0.54 (0.39–0.74)</td></tr><tr><td>24-hr avg Cu</td><td>3</td><td>0.03 (–0.09–0.05)</td></tr><tr><td>24-hr avg Zn</td><td>3</td><td>0.03 (–0.02–0.11)</td></tr><tr><td>24-hr avg Pb</td><td>3</td><td>0.08 (0.04–0.22)</td></tr><tr><td>Criteria gases</td></tr><tr><td>8-hr max O<sub>3</sub></td><td>13<sup><i>d</i></sup></td><td>0.85 (0.72–0.94)</td></tr><tr><td>1-hr max CO</td><td>3</td><td>0.62 (0.17–0.71)</td></tr><tr><td>1-hr max NO<sub>2</sub></td><td>8</td><td>0.64 (0.27–0.70)</td></tr><tr><td>1-hr max SO<sub>2</sub></td><td>10</td><td>–0.03 (–0.10–0.12)</td></tr><tr><td colspan="3">Abbreviations: avg, average; max, maximum. <sup><i>a</i></sup>These are partial correlations, computed as the correlations between residuals from linear models for each of the pollutants that included all of the covariates in our epidemiologic models; all correlations exclude data from 4 July 2001, 4 July 2002, and 5 July 2002. <sup><i>b</i></sup>Includes data from all sites at which PM<sub>2.5</sub> was measured. <sup><i>c</i></sup>Includes data from a subset of PM<sub>2.5</sub> sites at which PM<sub>2.5</sub> components were also measured (every 3 or 6 days). <sup><i>d</i></sup>Only two sites other than Tudor Ave. provided year-round O<sub>3</sub> data; restricting the analysis to these sites produced similar results: median, 0.84 (range, 0.82–0.87).</td></tr></table> |
606fe459ee9732f3df88c9922b12e0a7df688860458c894a6cefb1869f790349.png | simple | <table><tr><td></td><td>Tertiary hospitals (<i>n</i> = 50) Mean (SD) score</td><td>General hospitals (<i>n</i> = 109) Mean (SD) score</td></tr><tr><td>Reduction of rate of intubation and ventilation</td><td>4.5 (1.0)</td><td>4.8 (0.7)</td></tr><tr><td>Reduction in need for inter-hospital transfer</td><td>4.0 (1.2)</td><td>4.7 (0.7)</td></tr><tr><td>Reduction in length of stay</td><td>3.9 (1.0)</td><td>4.2 (0.8)</td></tr><tr><td>Reduction in complication rate</td><td>3.9 (1.2)</td><td>4.3 (0.9)</td></tr><tr><td>Improved patient tolerance</td><td>3.9 (1.1)</td><td>4.2 (0.9)</td></tr><tr><td>Reduced need for sedation</td><td>3.6 (1.2)</td><td>3.5 (1.2)</td></tr><tr><td>Parent/Carer Satisfaction</td><td>4.0 (0.9)</td><td>3.9 (1.1)</td></tr></table> |
fdfdd87746619c2c2d3f532707b46fbd2ef6f5ac2d016fd1a669c1a31559da5e.png | complex | <table><tr><td>Measurement year</td><td>2008</td><td>2010</td><td>2013</td></tr><tr><td>Participation</td><td></td><td></td><td></td></tr><tr><td>All measured children (n, % of eligible)</td><td>1142 (86)</td><td>1448 (85)</td><td>1868 (91)</td></tr><tr><td><i>Girls/boys (% of eligible)</i></td><td>85/86</td><td>84/85</td><td>91/90</td></tr><tr><td>Completed FQ (n, % of measured)</td><td>833 (73)</td><td>1085 (75)</td><td>1134 (61)</td></tr><tr><td><i>Girls/boys (% of measured)</i></td><td>76/70</td><td>76/74</td><td>61/61</td></tr><tr><td>Distribution of children according to individual socioeconomic characteristics from FQ</td><td></td><td></td><td></td></tr><tr><td><i>Maternal education % low/high</i></td><td>54/46</td><td>55/45</td><td>44/56</td></tr><tr><td><i>Maternal employment</i></td><td rowspan="2">79/21</td><td rowspan="2">82/18</td><td rowspan="2">85/15</td></tr><tr><td><i>% employed/not employed</i><sup><i>1</i></sup></td></tr></table> |
18b1792afc327080e3feac9dbac06415e6322fbc535b62f4d6c082c017e3afd1.png | simple | <table><tr><td>Importance of the Water Supply Issue to the Household</td><td>Percentage</td></tr><tr><td>Absolutely not important</td><td>10</td></tr><tr><td>Not important</td><td>10</td></tr><tr><td>Between important and not important</td><td>8</td></tr><tr><td>Important</td><td>38</td></tr><tr><td>Very important</td><td>34</td></tr></table> |
8daf526cee422bb7f1e3306bbcac7f5ecbcd9fa24e6d171a8d084686a87836d8.png | complex | <table><tr><td rowspan="2">Time</td><td rowspan="2">Side Swing (°)</td><td rowspan="2">Regions</td><td rowspan="2">Positioning Accuracy</td><td colspan="2">Average Offset</td><td colspan="2">Relative Accuracy</td></tr><tr><td>dx</td><td>dy</td><td>mx</td><td>my</td></tr><tr><td>27 December 2014 15:27</td><td>−3.820</td><td>Yili</td><td>13.141</td><td>−11.581</td><td>−6.212</td><td>1.665</td><td>1.721</td></tr><tr><td>9 February 2015 11:10</td><td>−5.532</td><td>Anyang</td><td>6.429</td><td>5.356</td><td>−3.557</td><td>1.355</td><td>1.399</td></tr><tr><td>16 March 2015 13:20</td><td>4.152</td><td>Songshan</td><td>7.020</td><td>4.271</td><td>−5.572</td><td>1.323</td><td>1.413</td></tr><tr><td>1 May 2015 16:13</td><td>3.318</td><td>Anyang</td><td>8.381</td><td>−3.564</td><td>−7.586</td><td>0.831</td><td>1.896</td></tr><tr><td>23 July 2015 15:27</td><td>−2.243</td><td>Yili</td><td>15.747</td><td>−14.197</td><td>6.815</td><td>1.385</td><td>1.125</td></tr><tr><td>12 September 2015 14:15</td><td>7.436</td><td>Dongying</td><td>18.288</td><td>15.734</td><td>−9.323</td><td>1.255</td><td>1.133</td></tr><tr><td>20 October 2015 13:30</td><td>−5.616</td><td>Sanya</td><td>21.099</td><td>16.388</td><td>−13.29</td><td>1.421</td><td>0.847</td></tr><tr><td>25 December 2015 16:55</td><td>2.378</td><td>Taiyuan</td><td>17.676</td><td>−14.988</td><td>−9.372</td><td>1.006</td><td>1.155</td></tr><tr><td colspan="3">RMS</td><td>14.464</td><td>11.916</td><td>8.197</td><td>1.302</td><td>1.374</td></tr></table> |
f2153633164c28f93c9eb548f2b361e0cbdef26de249c43b8abc135a9efd70a5.png | complex | <table><tr><td></td><td>Type 1 diabetes n = 199</td><td>All controls n = 178</td><td>p value</td></tr><tr><td>Sex (male:female)</td><td>98:101</td><td>84:94</td><td>0.69</td></tr><tr><td>Age (years)</td><td>14.4 ± 1.6</td><td>14.4 ± 2.1</td><td>0.80</td></tr><tr><td>Height (cm)</td><td>163 ± 10</td><td>162 ± 11</td><td>0.25</td></tr><tr><td>Weight (kg)</td><td>60.7 ± 14.3</td><td>54.7 ± 13.8</td><td><0.0001</td></tr><tr><td>BSA (m<sup>2</sup>)</td><td>1.65 ± 0.22</td><td>1.57 ± 0.23</td><td>0.0006</td></tr><tr><td colspan="4">Insulin administration (%)</td></tr><tr><td> Pump</td><td>60.8</td><td>–</td><td></td></tr><tr><td> Multiple injections</td><td>30.2</td><td>–</td><td></td></tr><tr><td colspan="4">Smoking status <i>n</i> (%)</td></tr><tr><td> Never smoked</td><td>181 (92.8)</td><td>63 (100)</td><td></td></tr><tr><td> Smoked few puffs to a whole cigarette in my life</td><td>9 (4.6)</td><td>0</td><td></td></tr><tr><td> Only 2 to 3 cigarettes in my life</td><td>1 (0.5)</td><td>0</td><td></td></tr><tr><td> More than 3, but fewer than 100 cigarettes in my life</td><td>1 (0.5)</td><td>0</td><td></td></tr><tr><td> >100 cigarettes in my life, none in the past month</td><td>1 (0.5)</td><td>0</td><td></td></tr><tr><td> >100 cigarettes in my life, some in the last month but not every day</td><td>1 (0.5)</td><td>0</td><td></td></tr><tr><td> >100 cigarettes in my life, at least 1 cigarette every day during the last month</td><td>2 [1]</td><td>0</td><td></td></tr><tr><td>BMI (kg/m<sup>2</sup>)</td><td>22.6 ± 4.3</td><td>20.6 ± 3.7</td><td><0.0001</td></tr><tr><td>SBP (mmHg)</td><td>113 ± 10</td><td>110 ± 9</td><td>0.0005</td></tr><tr><td>SBP <i>z</i>-score for height</td><td>0.2 ± 0.9</td><td>−0.1 ± 0.9</td><td>0.0011</td></tr><tr><td>DBP (mmHg)</td><td>62 ± 7</td><td>58 ± 7</td><td><0.0001</td></tr><tr><td>DBP <i>z</i>-score for height</td><td>−0.3 ± 0.6</td><td>−0.6 ± 0.7</td><td><0.0001</td></tr><tr><td>MBP (mmHg)</td><td>77 ± 7</td><td>75 ± 7</td><td>0.0053</td></tr><tr><td>PP (mmHg)</td><td>51 ± 9</td><td>52 ± 8</td><td>0.48</td></tr><tr><td>HR (bpm)</td><td>66 ± 9</td><td>68 ± 12</td><td>0.036</td></tr><tr><td>Diabetes duration (years)</td><td>7.2 ± 3.1</td><td>–</td><td>−</td></tr><tr><td>Glucose (mmol/l)</td><td>9.7 ± 4.4</td><td>4.7 ± 0.7</td><td><0.0001</td></tr><tr><td>HbA1c (%)</td><td>0.085 ± 0.012</td><td>0.054 ± 0.002</td><td><0.0001</td></tr><tr><td>HbA1c mmol/mol</td><td>84.9 ± 12.4</td><td>53.8 ± 2.4</td><td><0.0001</td></tr><tr><td>Cholesterol (mmol/L)</td><td>4.3 ± 0.88</td><td>4.24 ± 0.83</td><td>0.5158</td></tr><tr><td>HDL cholesterol (mmol/L)</td><td>1.6 ± 0.36</td><td>1.46 ± 0.28</td><td>0.0004</td></tr><tr><td>LDL cholesterol (mmol/L)</td><td>2.3 ± 0.71</td><td>2.36 ± 0.74</td><td>0.6109</td></tr><tr><td>Triglycerides (mmol/L)</td><td>0.84 ± 0.37</td><td>0.93 ± 0.40</td><td>0.0945</td></tr><tr><td>Creatinine (mmol/L)</td><td>54 ± 9</td><td>56 ± 11</td><td>0.1149</td></tr><tr><td>eGFR (mL/min/1.73 m<sup>2</sup>)</td><td>113 ± 17</td><td>108 ± 17</td><td>0.0405</td></tr></table> |
44845694700af06012dfdb2ee8097112f6cb7fd756e5a0225d1dc25ddf38bff9.png | simple | <table><tr><td></td><td>UK samples positive/total (%)</td><td>Nigerian samples positive/total (%)</td><td>p value</td></tr><tr><td>Molecular markers</td><td></td><td></td><td></td></tr><tr><td>ER</td><td>20/34 (58.8)</td><td>9/34 (26.5)</td><td>p = 0.0142</td></tr><tr><td>PR</td><td>18/34 (52.9)</td><td>10/34 (29.4)</td><td>p = 0.0846</td></tr><tr><td>ERBB2</td><td>15/34 (44.1)</td><td>8/34 (23.5)</td><td>p = 0.1241</td></tr><tr><td>CCND1</td><td>9/33 (27.3)</td><td>2/33 (6.1)</td><td>p = 0.0475</td></tr><tr><td>P53</td><td>13/34 (38.2)</td><td>17/34 (50)</td><td>p = 0.4637</td></tr><tr><td>Histological Grade</td><td></td><td></td><td></td></tr><tr><td>Grade 1</td><td>1/34 (2.9)</td><td>2/34 (5)</td><td>p = 1 (Fisher’s exact)</td></tr><tr><td>Grade 2</td><td>12/34 (35.3)</td><td>8/34 (23.5)</td><td>p = 0.4246</td></tr><tr><td>Grade 3</td><td>21/34 (61.8)</td><td>24/34 (70.6)</td><td>p = 0.6082</td></tr></table> |
909714223ec7c9a6688d04e5f0584142bcadf6d8900c12f3b840ae3c289b8abe.png | simple | <table><tr><td>Healthcare professional</td><td>Gender</td><td>Description of Role</td></tr><tr><td>Respiratory Physician</td><td>Female</td><td>Assessment of COPD and comorbidities, preparation and review of COPD treatment plans</td></tr><tr><td>Registered Clinic Nurse</td><td>Female</td><td>Support assessments, administer aspects of treatment plan (eg smoking cessation counselling, instruction in inhaler technique, case coordination</td></tr><tr><td>Research Assistant</td><td>Female</td><td>Case coordination, data entry and management</td></tr><tr><td>General Practitioner</td><td>Male</td><td>Prepare health care plan, receive and integrate test results in between study visits, provide referrals to specialists, allied health and Respiratory HEAL</td></tr></table> |
a6d03a20be2dfff1d9a42998098f9ff27032d25f3707ba2ebad2cebaa9df33a9.png | simple | <table><tr><td></td><td>Relative Risk</td><td>95% Confidence Interval</td><td>P-value</td></tr><tr><td>Gleason 7 vs. 6</td><td>1.37</td><td>1.19, 1.56</td><td><0.0001</td></tr><tr><td>Gleason 8 to10 vs. 6</td><td>1.56</td><td>1.37, 1.78</td><td><0.0001</td></tr><tr><td>Gleason 8 to10 vs. 7</td><td>1.14</td><td>1.04, 1.25</td><td>0.004</td></tr><tr><td>Surgical Margin R1 vs. R0</td><td>1.43</td><td>1.26, 1.62</td><td><0.0001</td></tr><tr><td>Stage 3a vs. 2</td><td>1.16</td><td>1.05, 1.28</td><td>0.002</td></tr><tr><td>Specialty:</td><td></td><td></td><td></td></tr><tr><td>Radiation oncology vs. Urology</td><td>1.26</td><td>1.15, 1.38</td><td><0.0001</td></tr></table> |
a32cc9cab6282d522df38705250d4430b454c96e84954a21a468de10783b7652.png | complex | <table><tr><td>Group</td><td colspan="2">≤35 years old</td><td colspan="2">36-38 years old</td><td colspan="2">39-40 years old</td><td colspan="2">>40 years old</td></tr><tr><td>Variable</td><td>RC</td><td><i>p</i></td><td>RC</td><td><i>p</i></td><td>RC</td><td><i>p</i></td><td>RC</td><td><i>p</i></td></tr><tr><td colspan="9">Laboratory outcomes</td></tr><tr><td>Fertilization rate</td><td>-0.001</td><td>NS</td><td>0.000</td><td>NS</td><td>0.001</td><td>NS</td><td>-0.002</td><td>NS</td></tr><tr><td>High quality D3 embryos</td><td>-0.001</td><td>NS</td><td>0.000</td><td>NS</td><td>0.000</td><td>NS</td><td>0.000</td><td>NS</td></tr><tr><td>High quality Embryo rate</td><td>-0.005</td><td><0.01</td><td>-0.006</td><td>0.025</td><td>0.002</td><td>NS</td><td>-0.002</td><td>NS</td></tr><tr><td>Blastocyst formation rate</td><td>-0.005</td><td><0.01</td><td>-0.007</td><td>0.042</td><td>0.004</td><td>NS</td><td>-0.004</td><td>NS</td></tr><tr><td>Transferred embryos</td><td>0.000</td><td><0.01</td><td>0.000</td><td>NS</td><td>0.000</td><td>NS</td><td>0.000</td><td>NS</td></tr><tr><td>Endometrium</td><td>0.000</td><td>NS</td><td>0.000</td><td>NS</td><td>0.001</td><td>NS</td><td>0.000</td><td>NS</td></tr></table> |
dbc3ce6045bcc1f19a7e136e963159c84938eba49c99377dbe87715f65835d31.png | simple | <table><tr><td> </td><td>All N = 15</td><td>18 years or younger N = 25</td><td>Over 18 Years N = 18</td></tr><tr><td>Medication class</td><td>Number prescribed this medication</td><td>Number prescribed this medication</td><td>Number prescribed this medication</td></tr><tr><td>Citalopram</td><td>5 (9.1%)</td><td>2 (8.0%)</td><td>3 (10.0%)</td></tr><tr><td>Escitalopram</td><td>3 (5.5%)</td><td>0 (0.0%)</td><td>3 (10.0%)</td></tr><tr><td>Fluoxetine</td><td>39 (70.9%)</td><td>23 (92.0%)</td><td>16 (53.3%)</td></tr><tr><td>Paroxetine</td><td>2 (3.6%)</td><td>0 (0.0%)</td><td>2 (6.7%)</td></tr><tr><td>Sertraline</td><td>2 (3.6%)</td><td>0 (0.0%)</td><td>2 (6.7%)</td></tr><tr><td>Mirtazapine</td><td>4 (7.3%)</td><td>0 (0.0%)</td><td>4 (13.5%)</td></tr></table> |
76eff35b7e02a323944cad15d66da4b3efb5deb2e9c08886572f5e4ad5da62ee.png | simple | <table><tr><td>Dependent variable</td><td>Independent variables</td><td>Odds ratio</td><td>CI (95%)</td><td><i>P</i> value</td></tr><tr><td></td><td>Adiponectin</td><td>0.7</td><td>0.33–1.07</td><td>0.06</td></tr><tr><td></td><td>Age</td><td>0.9</td><td>0.8–1.1</td><td>0.9</td></tr><tr><td> PCOS</td><td>WC</td><td>0.86</td><td>0.74–1.01</td><td>0.2</td></tr><tr><td></td><td>BMI</td><td>1.4</td><td>1–1.8</td><td>0.3</td></tr><tr><td></td><td>25OHD</td><td>1.9</td><td>1.3–2.5</td><td>0.002</td></tr></table> |
444bd9cb6bc41048b28dd89cf9e5c79ed690b6662fa9df03f689d09cd7965e6b.png | simple | <table><tr><td>Feature</td><td>Control</td><td>Treatment</td><td><i>p</i></td></tr><tr><td>Fat necrosis*</td><td>2.8±0.3</td><td>2.8±0.5</td><td>0.791</td></tr><tr><td>Inflammatory infiltrate*</td><td>3.6±0.1</td><td>3.4±0.2</td><td>0.247</td></tr><tr><td>Interstitial Edema**</td><td>4.0 (3.5-4.0)</td><td>3.5 (3.5-3.8)</td><td>0.382</td></tr><tr><td>Hemorrhagic foci**</td><td>4.0 (2.6-4.0)</td><td>3.5 (3.0-3.8)</td><td>0.622</td></tr></table> |
566cf0d1e29275e83184c1f49282995dad0101c86d88f9229c42032b5a739e31.png | simple | <table><tr><td>Age (mean ± SD) years</td><td>64.3 (± 3.5)</td></tr><tr><td>Gender male/female</td><td>12/8</td></tr><tr><td>Pre-op logMAR VA (mean ± SD)</td><td>1.15 ± 0.88</td></tr><tr><td>Post-op logMAR VA (mean ± SD)</td><td>0.55 ± 0.30</td></tr><tr><td>Lens statusPhakic/IOL</td><td>4/16</td></tr><tr><td>Duration of detachment (mean ± SD) days</td><td>6.25 ± 3.44</td></tr><tr><td>Quadrants detached</td><td>2.95 (± 0.75)</td></tr><tr><td>Location of the main breakSuperior/inferior quadrants</td><td>16/4</td></tr><tr><td>IOP pre-op</td><td>11.7 ± 2.6</td></tr><tr><td>IOP post-op</td><td>18.9 ± 4.9</td></tr><tr><td>IOP 2-hour post-op</td><td>16.8 ± 4.7</td></tr></table> |
f33515e95dd643e8eda02d48b1460bc6847dc5527d9f15e5b1582eae72e007f4.png | simple | <table><tr><td></td><td>Picture name</td><td>Related distractor</td><td>Unrelated distractor</td></tr><tr><td>Animals</td><td>Hert (deer)</td><td>Konijn</td><td>Piano</td></tr><tr><td></td><td>Konijn (rabbit)</td><td>Hert</td><td>Drumstel</td></tr><tr><td></td><td>Zwaan (swan)</td><td>Geit</td><td>Bus</td></tr><tr><td></td><td>Geit (goat)</td><td>Zwaan</td><td>Fluit</td></tr><tr><td>Clothing</td><td>Jas (jacket)</td><td>Hemd</td><td>Molen</td></tr><tr><td></td><td>Hemd (singlet)</td><td>Jas</td><td>Tafel</td></tr><tr><td></td><td>Rok (skirt)</td><td>Trui</td><td>Neus</td></tr><tr><td></td><td>Trui (sweater)</td><td>Rok</td><td>Banaan</td></tr><tr><td>Transportation</td><td>Auto (car)</td><td>Bus</td><td>Kanon</td></tr><tr><td></td><td>Bus (bus)</td><td>Auto</td><td>Konijn</td></tr><tr><td></td><td>Trein (train)</td><td>Fiets</td><td>Kast</td></tr><tr><td></td><td>Fiets (bicycle)</td><td>Trein</td><td>Trui</td></tr><tr><td>Buildings</td><td>Kerk (church)</td><td>Fabriek</td><td>Zwaan</td></tr><tr><td></td><td>Fabriek (factory)</td><td>Kerk</td><td>Zwaard</td></tr><tr><td></td><td>Molen (mill)</td><td>Kasteel</td><td>Dolk</td></tr><tr><td></td><td>Kasteel (castle)</td><td>Molen</td><td>Oor</td></tr><tr><td>Weapons</td><td>Dolk (dagger)</td><td>Zwaard</td><td>Arm</td></tr><tr><td></td><td>Zwaard (sword)</td><td>Dolk</td><td>Been</td></tr><tr><td></td><td>Kanon (cannon)</td><td>Pistool</td><td>Bed</td></tr><tr><td></td><td>Pistool (gun)</td><td>Kanon</td><td>Kan</td></tr><tr><td>Kitchenware</td><td>Kan (pitcher)</td><td>Beker</td><td>Fabriek</td></tr><tr><td></td><td>Beker (cup)</td><td>Kan</td><td>Pistool</td></tr><tr><td></td><td>Bord (plate)</td><td>Glas</td><td>Rok</td></tr><tr><td></td><td>Glas (glass)</td><td>Bord</td><td>Kerk</td></tr><tr><td>Furniture</td><td>Bed (bed)</td><td>Tafel</td><td>Gitaar</td></tr><tr><td></td><td>Tafel (table)</td><td>Bed</td><td>Kasteel</td></tr><tr><td></td><td>Bureau (desk)</td><td>Kast</td><td>Geit</td></tr><tr><td></td><td>Kast (wardrobe)</td><td>Bureau</td><td>Molen</td></tr><tr><td>Body parts</td><td>Neus (nose)</td><td>Arm</td><td>Auto</td></tr><tr><td></td><td>Arm (arm)</td><td>Neus</td><td>Peer</td></tr><tr><td></td><td>Been (leg)</td><td>Oor</td><td>Appel</td></tr><tr><td></td><td>Oor (ear)</td><td>Been</td><td>Beker</td></tr><tr><td>Fruit</td><td>Ananas (pineapple)</td><td>Banaan</td><td>Hert</td></tr><tr><td></td><td>Appel (apple)</td><td>Peer</td><td>Fiets</td></tr><tr><td></td><td>Banaan (banana)</td><td>Ananas</td><td>Trein</td></tr><tr><td></td><td>Peer (pear)</td><td>Appel</td><td>Hemd</td></tr><tr><td>Music instruments</td><td>Drumstel (drums)</td><td>Gitaar</td><td>Bureau</td></tr><tr><td></td><td>Gitaar (guitar)</td><td>Drumstel</td><td>Jas</td></tr><tr><td></td><td>Fluit (flute)</td><td>Piano</td><td>Bord</td></tr><tr><td></td><td>Piano (piano)</td><td>Fluit</td><td>Glas</td></tr></table> |
4b9a3307499d08b306d89039f891a451a6eb69a59eb488924d1ba89f1e995caa.png | complex | <table><tr><td>Secondary disability</td><td>Selection</td></tr><tr><td>Difficulties managing daily life</td><td>Societal support<sup>a</sup> in terms of different forms of housing conditions</td></tr><tr><td>Problems at school</td><td>Special education (school for children with intellectual development disorders, primary school level)</td></tr><tr><td>Psychiatric disorder<sup>b</sup></td><td>Average cost of depression, bipolar disorder, generalized anxiety disorder and schizophrenia</td></tr><tr><td>Alcohol/drug abuse</td><td>Alcohol abuse and/or illicit drug use</td></tr><tr><td rowspan="2">Suicidal ideation</td><td>No separate calculation</td></tr><tr><td>Included in other cost references</td></tr><tr><td rowspan="2">Criminality</td><td>No separate calculation</td></tr><tr><td>Cost included in alcohol/drug abuse</td></tr><tr><td rowspan="2">Inappropriate sexual behaviour</td><td>Not included</td></tr><tr><td>Lack of data</td></tr><tr><td>Reduced working capacity</td><td>Productivity loss for individuals without employment</td></tr><tr><td rowspan="2">Mortality</td><td>No separate calculation</td></tr><tr><td>Cost included in alcohol/drug abuse</td></tr><tr><td>Informal caring</td><td>Productivity loss for family member/relative/significant other</td></tr></table> |
e488b64fb064431a304170f06c2c3531aafdf30b444861111798ba905ae2a45d.png | simple | <table><tr><td>Variable</td><td>FLEEOX (n=99) (%)</td><td>XELOX (n=99) (%)</td><td><i>P</i></td></tr><tr><td>Response to NAC</td><td></td><td></td><td>0.026</td></tr><tr><td> CR</td><td>13 (13.1)</td><td>3 (3.0)</td><td></td></tr><tr><td> PR</td><td>67 (67.7)</td><td>65 (65.7)</td><td></td></tr><tr><td> SD</td><td>9 (9.1)</td><td>16 (16.2)</td><td></td></tr><tr><td> PD</td><td>10 (10.1)</td><td>15 (15.2)</td><td></td></tr><tr><td>RR (CR plus PR)</td><td>80 (80.8)</td><td>68 (68.7)</td><td>0.018</td></tr><tr><td>DCR (CR plus PR plus SD)</td><td>89 (89.9)</td><td>84 (84.8)</td><td>0.196</td></tr></table> |
81328528433caae1f681e3544b9f2a96a9a565cc64e2631ab8b9dbd3a338636d.png | complex | <table><tr><td rowspan="2">Characteristics</td><td>Altitude <1500 m</td><td>Altitude >1500 m</td><td rowspan="2"><i>p</i>-value</td></tr><tr><td><i>n</i> = 26,896</td><td><i>n</i> = 3978</td></tr><tr><td>COPD prevalence (%)</td><td>9.9</td><td>8.5</td><td><0.005</td></tr><tr><td>Mean FEV<sub>1</sub> (Litre, SD)</td><td>2.66 (0,85)</td><td>2.45 (0.78)</td><td>0.010</td></tr><tr><td>Mean FVC (Litre, SD)</td><td>3.47 (1.05)</td><td>3.20 (0.90)</td><td><0.001</td></tr><tr><td>Mean FEV<sub>1</sub>/FVC (SD)</td><td>76.8 (8.8)</td><td>76.2 (10.0)</td><td><0.001</td></tr><tr><td>Sex – female (%)</td><td>54.9</td><td>62.1</td><td><0.001</td></tr><tr><td>Age (Mean, SD)</td><td>56.2 (11.3)</td><td>55.1 (11.3)</td><td><0.001</td></tr><tr><td>Never-smoker (%)</td><td>48.6</td><td>56.5</td><td><0.001</td></tr><tr><td>Dusty job (%)</td><td>36.1</td><td>24.5</td><td><0.001</td></tr><tr><td>Tuberculosis (%)<sup>a</sup></td><td>3.5</td><td>0.4</td><td><0.001</td></tr><tr><td>Education >12 years (%)</td><td>23.6</td><td>9.5</td><td><0.001</td></tr><tr><td>Prior lung function test, ever (%)<sup>b</sup></td><td>28.1</td><td>4.1</td><td><0.001</td></tr><tr><td>Self-reported diagnosis of COPD (%)</td><td>5.1</td><td>3.9</td><td><0.001</td></tr><tr><td>Proportion of correct prior diagnosis of COPD (%)</td><td>37.0</td><td>31.2</td><td>0.158</td></tr><tr><td>Proportion of undiagnosed COPD (%)</td><td>80.8</td><td>85.8</td><td>0.029</td></tr></table> |
3831be9a5acaa234b9f172f3da2c17b5fe9529602845136d9c4274722d58de32.png | simple | <table><tr><td>Animal yields</td><td>Advantages</td><td>Disadvantages</td></tr><tr><td>Milk, Eggs</td><td>Easily measurable, almost complete edible</td><td>Variation in protein, fat and energy yield, analyses may be useful</td></tr><tr><td>Body weight gain</td><td>Easily measurable</td><td>High portion of non edible fractions in the gains</td></tr><tr><td>Carcass weight</td><td>Easily measurable</td><td>Contains still fractions which are not edible (e.g., bones)</td></tr><tr><td>Meat, edible fraction</td><td>Completely edible</td><td>Categorization and separation not easy</td></tr><tr><td>Edible protein</td><td>Most important objective of animal production; comparison of various methods and sources to produce protein of animal origin</td><td>Categorization of various fractions as edible and difficulties to measure; additional analytical work; variation in N/protein content</td></tr></table> |
8008a7a6bddb39215bde685c8405fc6b32c77fdc63c46749a5399d10bafaf471.png | simple | <table><tr><td></td><td>Number (%)</td><td>Mean ± SD</td><td>Range</td></tr><tr><td>Patient characteristics</td></tr><tr><td>Age (year)</td><td>52</td><td>44.8 ± 14</td><td>22–78</td></tr><tr><td>Gender</td></tr><tr><td> Male</td><td>34</td><td></td><td></td></tr><tr><td> Female</td><td>18</td><td></td></tr><tr><td>Seizures at presentation</td><td>38 (73.1%)</td><td></td><td></td></tr><tr><td> Antiepileptic drugs</td><td>37</td><td></td></tr><tr><td> Seizure-free</td><td>20</td><td></td></tr><tr><td> Recurrent seizure</td><td>18</td><td></td></tr><tr><td>No seizures at presentation</td><td>14 (29.9%)</td><td></td></tr><tr><td>Neurological function (RTOG)</td><td>52</td><td>1.19 ± 1.15</td><td>0–3</td></tr><tr><td> No neurological symptoms</td><td>17 (32.7%)</td><td></td><td></td></tr><tr><td> Minor neurological symptoms</td><td>21 (40.4%)</td><td></td></tr><tr><td> Moderate neurological symptoms</td><td>14 (26.9%)</td><td></td></tr><tr><td>Professions (<i>n</i> = 52)</td></tr><tr><td> High education</td><td>26 (50%)</td><td></td><td></td></tr><tr><td> Low education</td><td>18 (34.6%)</td><td></td><td></td></tr><tr><td> Retired</td><td>8 (15.4%)</td><td></td><td></td></tr><tr><td>Work situation (<i>n</i> = 52)</td></tr><tr><td> Working fully</td><td>25 (48%)</td><td></td><td></td></tr><tr><td> Working half time</td><td>11 (21%)</td><td></td><td></td></tr><tr><td> Not working, due to illness</td><td>4 (8%)</td><td></td><td></td></tr><tr><td> Retired, unrelated to illness</td><td>8 (15%)</td><td></td><td></td></tr><tr><td> Students</td><td>2 (4%)</td><td></td><td></td></tr><tr><td> Unemployed</td><td>2 (4%)</td><td></td><td></td></tr><tr><td>Changes in professional situation</td><td>19 (36%)</td><td></td><td></td></tr><tr><td>Tumor characteristics</td></tr><tr><td>Affected hemisphere</td></tr><tr><td> Right</td><td>20 (38.5%)</td><td></td><td></td></tr><tr><td> Left</td><td>31 (38.5%)</td><td></td><td></td></tr><tr><td> Bilateral</td><td>1 (1.9%)</td><td></td><td></td></tr><tr><td>Tumor location</td><td>52</td><td></td><td></td></tr><tr><td>Non-eloquent cortex</td><td>8</td><td></td><td></td></tr><tr><td>Non-eloquent cortico-subcortical</td><td>12</td><td></td><td></td></tr><tr><td>Eloquent cortico-subcortical</td><td>32</td><td></td><td></td></tr><tr><td> Insula</td><td>9</td><td></td><td></td></tr><tr><td> SMA<sup>a</sup>/Pre SMA</td><td>5/2</td><td></td><td></td></tr><tr><td> Primary somatosensory area</td><td>6</td><td></td><td></td></tr><tr><td> Primary motor area</td><td>4</td><td></td><td></td></tr><tr><td> Language area</td><td>6</td><td></td><td></td></tr><tr><td>Tumor volume (cm<sup>3</sup>)</td><td>50</td><td>69.3 ± 57.3</td><td>2.8–267.8</td></tr><tr><td>Smaller (<61 cm<sup>3</sup>)</td><td>24</td><td></td><td></td></tr><tr><td>Larger (>61 cm<sup>3</sup>)</td><td>26</td><td></td><td></td></tr></table> |
2920bc2ebe5ce728a65288c0b6c5e083e48a3b51d01228c35c8801e4ad708d2f.png | simple | <table><tr><td>Symptoms</td><td>Frequency</td><td>Number</td><td>Percentage</td></tr><tr><td>Sneezing</td><td>No symptoms</td><td>1076</td><td>69.70%</td></tr><tr><td></td><td>Occasional</td><td>398</td><td>25.80%</td></tr><tr><td></td><td>Frequent</td><td>69</td><td>4.50%</td></tr><tr><td>Cough</td><td>No symptoms</td><td>1380</td><td>89.40%</td></tr><tr><td></td><td>Occasional</td><td>149</td><td>9.70%</td></tr><tr><td></td><td>Frequent</td><td>14</td><td>0.90%</td></tr></table> |
dc1156be60b705a9ab6ae633fd43f0ef9ad77dc42d35d51eb2e4ff9ba1c81604.png | complex | <table><tr><td rowspan="2">Compound</td><td>Concentration</td><td>Relative activity</td></tr><tr><td>(mM)</td><td>(%)</td></tr><tr><td>dl-<i>threo</i>-<i>β</i>-phenylserine</td><td>20</td><td>100</td></tr><tr><td>d-<i>threo</i>-<i>β</i>-phenylserine</td><td>10</td><td>0</td></tr><tr><td>dl-<i>erythro</i>-<i>β</i>-phenylserine</td><td>20</td><td>840</td></tr><tr><td>dl-<i>threo</i>-(2-thienyl)serine</td><td>20</td><td>530</td></tr><tr><td>(<i>S</i>)-phenylethanol</td><td>10</td><td>6.9</td></tr><tr><td>dl-hydroxynorvaline</td><td>20</td><td>0</td></tr><tr><td>l-threonine</td><td>10</td><td>0</td></tr><tr><td>d-threonine</td><td>10</td><td>0</td></tr><tr><td>l-<i>allo</i>-threonine</td><td>10</td><td>0</td></tr><tr><td>d-<i>allo</i>-threonine</td><td>10</td><td>0</td></tr><tr><td>l-serine</td><td>10</td><td>0</td></tr><tr><td>d-serine</td><td>10</td><td>0</td></tr><tr><td>l-phenylalanine</td><td>10</td><td>0</td></tr><tr><td>d-phenylalanine</td><td>10</td><td>0</td></tr></table> |
20b11501197a133e660c0ac9a2ddac7ce2d1d41df21324a2fc9ea99947c1c7d8.png | complex | <table><tr><td></td><td colspan="2">Controls</td><td colspan="2">Earthquake victims</td></tr><tr><td>Measures</td><td>Mean</td><td>SD</td><td>Mean</td><td>SD</td></tr><tr><td>ISI</td><td>5.05</td><td>3.5</td><td>6.35</td><td>4</td></tr><tr><td>IUS-12</td><td>35.00</td><td>15.2</td><td>42.54</td><td>16.7</td></tr><tr><td>URS total score*</td><td>121.03</td><td>12.1</td><td>128.56</td><td>13.3</td></tr><tr><td>URS emotional uncertainty*</td><td>26.53</td><td>6.1</td><td>31.69</td><td>7.4</td></tr><tr><td>URS desire for control</td><td>47.22</td><td>7.2</td><td>46.13</td><td>7.7</td></tr><tr><td>URS cognitive uncertainty</td><td>47.41</td><td>8.5</td><td>51.10</td><td>8.9</td></tr><tr><td>STAI*</td><td>37.63</td><td>8.2</td><td>42.46</td><td>7.8</td></tr><tr><td>BDI</td><td>6.54</td><td>5.2</td><td>8.56</td><td>5.8</td></tr><tr><td>ASI-3 total score*</td><td>10.90</td><td>8.3</td><td>18.21</td><td>13.3</td></tr><tr><td>ASI-3 physical concerns</td><td>3.41</td><td>3.9</td><td>5.46</td><td>5.6</td></tr><tr><td>ASI-3 cognitive concerns*</td><td>4.05</td><td>3.6</td><td>6.77</td><td>5.1</td></tr><tr><td>ASI-3 social concerns*</td><td>3.44</td><td>3.4</td><td>6.25</td><td>5.1</td></tr><tr><td>EPQ-R Extraversion/Introversion</td><td>9.05</td><td>2.8</td><td>8.48</td><td>3.2</td></tr><tr><td>EPQ-R neuroticism*</td><td>4.46</td><td>2.7</td><td>6.33</td><td>3.3</td></tr><tr><td>EPQ-R psychoticism</td><td>3.22</td><td>1.9</td><td>2.67</td><td>1.5</td></tr></table> |
ca21d22cafe35b9e6b76bc3dfad32ba3b4c06d477db3b53cec5426ccf9309671.png | simple | <table><tr><td></td><td>No (%)</td><td>OR</td><td>Yes (%)</td><td>OR (95% CI)</td><td><i>P</i></td></tr><tr><td>High TG</td><td>10.6</td><td>1</td><td>23.3</td><td>1.4 (1.0–2.0)</td><td> 0.0334</td></tr><tr><td>Low HDL-C</td><td>11.0</td><td>1</td><td>12.6</td><td>0.9 (0.6–1.2)</td><td> 0.4507</td></tr><tr><td>Hyperglycemia</td><td>11.0</td><td>1</td><td>15.5</td><td>1.5 (0.9–2.5)</td><td> 0.0890</td></tr><tr><td>MetS</td><td>10.8</td><td>1</td><td>51.9</td><td>2.8 (1.5–5.4)</td><td> 0.0014</td></tr><tr><td>Insulin</td><td>7.7</td><td>1</td><td>16.6</td><td>1.6 (1.4–2.0)</td><td><0.0001</td></tr><tr><td>HOMA-IR</td><td>7.5</td><td>1</td><td>15.4</td><td>1.6 (1.4–2.0)</td><td><0.0001</td></tr></table> |
a140caf76f612107390af42ffcc993777da7bf31b3f6fb54011099769c82209d.png | simple | <table><tr><td></td><td>Left thalamic infarct patients (<i>n</i> = 12)</td><td>Healthy control participants (<i>n</i> = 25)</td><td><i>P</i> value</td><td>dMTT subgroup (<i>n</i> = 7)</td><td>iMTT subgroup (<i>n</i> = 5)</td><td><i>P</i> value</td></tr><tr><td>Age (years)</td><td>53.2 (14.6) [25, 75]</td><td>52.6 (11.6) [25, 69]</td><td>0.86</td><td>58.9 (16.6) [25, 75]</td><td>45.2 (6.3) [38, 52]</td><td>0.12</td></tr><tr><td>Sex (female (F)/male (M))</td><td>3F/9M</td><td>15F/10M</td><td>0.05</td><td>1F/6M</td><td>2F/3M</td><td>0.31</td></tr><tr><td>Education level (years)</td><td>12.8 (4.1) [5, 17]</td><td>13.6 (4.1) [5, 21]</td><td>0.25</td><td>12.3 (4.2) [5, 17]</td><td>11 (4.2) [5, 17]</td><td>0.69</td></tr><tr><td>Handedness (right (R)/left (L)/ambidextrous (A))</td><td>11 R/1A</td><td>22R/3L</td><td>0.17</td><td>6 R/1A</td><td>5 R</td><td>0.38</td></tr><tr><td>Time since onset</td><td>589 (588.9) days [3 months, 4 years 11 months]</td><td>–</td><td>–</td><td>527 (647.2) days [3 months, 4 years 11 months]</td><td>675 (556.1) days [3 months, 3 years 8 months]</td><td>0.69</td></tr><tr><td>Normalized volume of overall lesions (mm<sup>3</sup>)</td><td>516.8 (265.2) [30, 982]</td><td>–</td><td>–</td><td>679.6 (160.7) [538, 982]</td><td>289 (208.5) [30, 605]</td><td>0.005</td></tr></table> |
c9ae4665cbcf57638649ec5ef884d67822a31032e9ea117164ebcc57c74d5f3d.png | simple | <table><tr><td>Clinical Training Programs in</td><td>Nation</td><td>Commenced</td></tr><tr><td>ROMP </td><td>ThailandThe Philippines Malaysia </td><td>2007 (completed) 20092011</td></tr><tr><td>DRMP </td><td>The Philippines Thailand </td><td>20102010</td></tr><tr><td>NMP </td><td>BangladeshThailand</td><td>20102011 </td></tr></table> |
3416b363120ed9b1c575aaa60e28bacbd01bbbc7e75137f582f73d975baf9849.png | complex | <table><tr><td colspan="2">Absolute power density (mean ± SE, μV<sup>2</sup>)</td><td colspan="2">Relative power density<sup>a </sup>(mean ± SE, %)</td></tr><tr><td>Eyes closed</td><td>Eyes open</td><td>Eyes closed</td><td>Eyes open</td></tr><tr><td>23.9 ± 3.5*</td><td>2.4 ± 0.2</td><td>60.8 ± 2.4*</td><td>26.0 ± 1.7</td></tr></table> |
c0e987a58fcca7696ec838f87cc0bff05354fabdd65d0903b8739056e3a65956.png | complex | <table><tr><td colspan="2">Number of families<sup><i>b</i></sup></td><td>46</td></tr><tr><td rowspan="5">Number of children < 12<sup><i>b</i></sup></td><td>Age (years)</td><td> </td></tr><tr><td><i>0–3</i></td><td>28</td></tr><tr><td><i>3–6</i></td><td>27</td></tr><tr><td><i>6–12</i></td><td>23</td></tr><tr><td><i>Total</i></td><td>78</td></tr><tr><td rowspan="4">Number of children attending Mobile Crèches center<sup><i>b</i></sup></td><td><i>0–3</i></td><td>27</td></tr><tr><td><i>3–6</i></td><td>26</td></tr><tr><td><i>6–12</i></td><td>23</td></tr><tr><td><i>Total</i></td><td>76</td></tr><tr><td colspan="2">Average duration of attendance at Mobile Crèches center (child-days per child)<sup><i>c</i></sup></td><td>48</td></tr></table> |
a2edb1880adde3fb543da054c3eb586fad44d80cd12e33a655bae24dc17cca00.png | simple | <table><tr><td>History</td><td>• Activity and employment status</td></tr><tr><td></td><td>• Description of LBP</td></tr><tr><td></td><td>• Response to previous treatment</td></tr><tr><td></td><td>• Co-morbidities and medications</td></tr><tr><td>Examination</td><td>• Vitals (height, weight, blood pressure)</td></tr><tr><td></td><td>• Orthopedic exam (Lasegue, Patrick Fabre, Kemp, Gaenslen, Femoral Nerve Stretch)</td></tr><tr><td></td><td>• Neurologic exam (motor, sensory, reflex evaluation)</td></tr><tr><td></td><td>• Soft tissue evaluation</td></tr><tr><td>Imaging</td><td>• X-ray results (obtained if clinically warranted)</td></tr><tr><td></td><td>• DEXA results (obtained if clinically warranted)</td></tr><tr><td>Biomechanical Assessment</td><td>• Torso strength (flexion, extension)</td></tr><tr><td></td><td>• Torso endurance (flexion, extension, lateral bridge)</td></tr><tr><td></td><td>• Lumbar range of motion (flexion, extension, lateral bending, rotation)</td></tr><tr><td>Psychosocial Assessment</td><td>• Disability (modified Roland Morris)[32,33]</td></tr><tr><td></td><td>• General health status (EuroQol) [34,35]</td></tr><tr><td></td><td>• Fear avoidance (Fear Avoidance Beliefs Questionnaire)[36]</td></tr><tr><td></td><td>• Kinesiophobia (Tampa Scale of Kinesiophobia)[37]</td></tr><tr><td></td><td>• Coping style (Vanderbilt Pain Management Inventory)[38,39]</td></tr><tr><td></td><td>• Pain self-efficacy (PSEQ)[40]</td></tr><tr><td></td><td>• Depression (CES-D)[41,42]</td></tr><tr><td>Preferences</td><td>• Which modalities were preferred</td></tr><tr><td></td><td>• Expectations for improvement with each modality (5 point scale)</td></tr></table> |
d31fed9c5b25e4529d14b57372633919cec8e5344ee476f9f6a31903aa95c192.png | complex | <table><tr><td></td><td colspan="4">WILD TYPE</td><td colspan="4">ADIPONECTIN-/-</td></tr><tr><td></td><td colspan="2">SHAM</td><td colspan="2">TAC</td><td colspan="2">SHAM</td><td colspan="2">TAC</td></tr><tr><td></td><td>STD</td><td>ω-3 PUFA</td><td>STD</td><td>ω-3 PUFA</td><td>STD</td><td>ω-3 PUFA</td><td>STD</td><td>ω-3 PUFA</td></tr><tr><td>Serum Adiponectin (μg·ml<sup>-1</sup>)</td><td><i>7.94 ± 1.23</i></td><td><i>8.74 ± 1.35</i></td><td><i>7.72 ± 1.27</i></td><td><i>7.48 ± 1.23</i></td><td><i>1.70 ± 0.12</i></td><td><i>1.56 ± 0.10</i></td><td><i>1.50 ± 0.10</i></td><td><i>1.49 ± 0.10</i></td></tr><tr><td>Serum HMW Adiponectin (μg·ml<sup>-1</sup>)</td><td><i>0.55 ± 0.03</i></td><td><i>0.78 ± 0.08#</i></td><td><i>0.63 ± 0.05</i></td><td><i>0.73 ± 0.08</i></td><td><i>0.18 ± 0.03</i></td><td><i>0.18 ± 0.03</i></td><td><i>0.19 ± 0.02</i></td><td><i>0.19 ± 0.03</i></td></tr><tr><td>Adiponectin mRNA in Epididymal Fat</td><td><i>1.00 ± 0.17</i></td><td><i>1.10 ± 0.10</i></td><td><i>1.04 ± 0.14</i></td><td><i>1.18 ± 0.27</i></td><td><i>0</i></td><td><i>0</i></td><td><i>0</i></td><td><i>0</i></td></tr><tr><td>PDK4 mRNA in LV</td><td><i>1.00 ± 0.35</i></td><td><i>0.30 ± 0.03#</i></td><td><i>0.29 ± 0.04*</i></td><td><i>0.29 ± 0.04</i></td><td><i>0.27 ± 0.03</i></td><td><i>0.40 ± 0.11</i></td><td><i>0.37 ± 0.08</i></td><td><i>0.48 ± 0.14</i></td></tr><tr><td>UCP3 mRNA in LV</td><td><i>1.00 ± 0.14</i></td><td><i>0.88 ± 0.13</i></td><td><i>0.39 ± 0.07*</i></td><td><i>0.47 ± 0.12</i></td><td><i>0.89 ± 0.12</i></td><td><i>0.96 ± 0.11</i></td><td><i>0.49 ± 0.09</i></td><td><i>0.59 ± 0.10</i></td></tr><tr><td>Serum Glucose (mM)</td><td><i>12.7 ± 0.6</i></td><td><i>11.6 ± 0.8</i></td><td><i>12.6 ± 1.0</i></td><td><i>11.4 ± 0.9</i></td><td><i>13.0 ± 0.9</i></td><td><i>12.7 ± 0.7</i></td><td><i>11.7 ± 0.4</i></td><td><i>13.1 ± 1.1</i></td></tr><tr><td>Serum FFA (mM)</td><td><i>0.69 ± 0.05</i></td><td><i>0.55 ± 0.04</i></td><td><i>0.76 ± 0.14</i></td><td><i>0.55 ± 0.07</i></td><td><i>0.82 ± 0.08</i></td><td><i>0.47 ± 0.06</i></td><td><i>0.61 ± 0.07</i></td><td><i>0.52 ± 0.08</i></td></tr><tr><td>Serum Insulin (ng·ml<sup>-1</sup>)</td><td><i>0.66 ± 0.16</i></td><td><i>0.90 ± 0.20</i></td><td><i>0.66 ± 0.16</i></td><td><i>0.48 ± 0.10</i></td><td><i>0.84 ± 0.23</i></td><td><i>0.54 ± 0.11</i></td><td><i>0.60 ± 0.10</i></td><td><i>0.34 ± 0.10</i></td></tr><tr><td>Serum Leptin (ng·ml<sup>-1</sup>)</td><td><i>2.56 ± 0.51</i></td><td><i>2.80 ± 0.70</i></td><td><i>1.62 ± 0.37</i></td><td><i>1.18 ± 0.28*</i></td><td><i>3.83 ± 1.50</i></td><td><i>2.28 ± 0.82</i></td><td><i>1.85 ± 0.43</i></td><td><i>0.78 ± 0.14</i></td></tr><tr><td>Serum Triglycerides (mg·ml<sup>-1</sup>)</td><td><i>0.26 ± 0.05</i></td><td><i>0.25 ± 0.06</i></td><td><i>0.25 ± 0.07</i></td><td><i>0.28 ± 0.06</i></td><td><i>0.40 ± 0.09</i></td><td><i>0.23 ± 0.08</i></td><td><i>0.30 ± 0.04</i></td><td><i>0.25 ± 0.06</i></td></tr></table> |
e9b6f4a231310291b27e86c22bf773aba0d8179650f22046a08aa7083eb816cb.png | complex | <table><tr><td colspan="2"></td><td colspan="3">HAQ-P<sup>b</sup></td><td></td><td colspan="3">HAQ-T<sup>c</sup></td></tr><tr><td></td><td></td><td><i>Relation to the therapist</i></td><td><i>Satisfaction with therapeutic outcome</i></td><td><i>Helping alliance</i></td><td></td><td><i>Relation to the patient</i></td><td><i>Satisfaction with therapeutic outcome</i></td><td><i>Helping alliance</i></td></tr><tr><td>IIP<sup>a</sup></td><td><i>M (SD)</i></td><td><i>r</i></td><td><i>r</i></td><td><i>r</i></td><td></td><td><i>r</i></td><td><i>r</i></td><td><i>r</i></td></tr><tr><td>total score</td><td>14.92 (3.69)</td><td>−0.10</td><td>−0.15*</td><td>−0.14*</td><td></td><td>−0.05</td><td>− 0.05</td><td>−0.06</td></tr><tr><td>Domineering/ controlling</td><td>8.31 (5.10)</td><td>−0.14*</td><td>−0.10</td><td>− 0.13*</td><td></td><td>− 0.12</td><td>−0.12</td><td>− 0.13*</td></tr><tr><td>Vindictive/ self-centred</td><td>11.02 (5.19)</td><td>−0.17**</td><td>−0.18**</td><td>− 0.19**</td><td></td><td>− 0.11</td><td>−0.11</td><td>− 0.12</td></tr><tr><td>Cold/ distant</td><td>14.79 (6.04)</td><td>−0.21*</td><td>−0.21**</td><td>− 0.23**</td><td></td><td>− 0.08</td><td>−0.08</td><td>− 0.09</td></tr><tr><td>Socially inhibited</td><td>17.93 (6.71)</td><td>−0.16*</td><td>−0.23**</td><td>− 0.22**</td><td></td><td>− 0.11</td><td>−0.11</td><td>− 0.12*</td></tr><tr><td>Non-assertive</td><td>20.04 (6.68)</td><td>−0.03</td><td>−0.12</td><td>− 0.08</td><td></td><td>0.00</td><td>0.01</td><td>0.01</td></tr><tr><td>Overly accommodating</td><td>17.49 (5.83)</td><td>0.07</td><td>−0.00</td><td>0.03</td><td></td><td>0.10</td><td>0.10</td><td>0.11</td></tr><tr><td>Self-sacrificing</td><td>18.71 (5.29)</td><td>0.11</td><td>−0.01</td><td>0.06</td><td></td><td>0.08</td><td>0.08</td><td>0.09</td></tr><tr><td>Intrusive/ needy</td><td>11.10 (5.33)</td><td>0.05</td><td>−0.09</td><td>0.08</td><td></td><td>−0.01</td><td>−0.02</td><td>− 0.02</td></tr></table> |
e1a9141746cb288895915dd6acc419644b97479eac559b3fc2d69b90dfae94bf.png | complex | <table><tr><td></td><td>Study population</td><td colspan="2">Respondents</td><td colspan="2">Respondents having consultations concerning sickness certification at least a few times a year</td></tr><tr><td></td><td>n</td><td>n</td><td>% of study population</td><td>n</td><td>% of the respondents</td></tr><tr><td>All</td><td>7665</td><td>5455</td><td>71</td><td>4019</td><td>74</td></tr><tr><td><i>County</i></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Stockholm</td><td>6794</td><td>4827</td><td>71</td><td>3446</td><td>71</td></tr><tr><td>Östergötland</td><td>871</td><td>628</td><td>72</td><td>573</td><td>91</td></tr><tr><td><i>Sex</i></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Women</td><td>3646</td><td>2710</td><td>74</td><td>2007</td><td>74</td></tr><tr><td>Men</td><td>4019</td><td>2745</td><td>68</td><td>2012</td><td>73</td></tr><tr><td><i>Educational level</i><sup>1</sup></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Non-specialist</td><td></td><td>1381</td><td></td><td>1046</td><td>76</td></tr><tr><td>Specialist</td><td></td><td>3995</td><td></td><td>2947</td><td>74</td></tr><tr><td>No information</td><td></td><td>79</td><td></td><td>26</td><td>33</td></tr><tr><td><i>Mean age </i>(years)</td><td>48.2</td><td>48.3</td><td></td><td>47.7</td><td></td></tr></table> |
c90b7af4dc812c097f069676dc73d0e23127323f91e9e908b2ed419d4b76fdb9.png | simple | <table><tr><td>Symptoms (Discomforts)</td><td>after 1 ED</td><td>after 2 ED</td><td>after 3 ED</td><td><i>n</i></td></tr><tr><td>headache</td><td>3 (8%)</td><td>7 (19%)</td><td>3 (8%)</td><td>13</td></tr><tr><td>light chest pain</td><td>-</td><td>-</td><td>2 (5%)</td><td>2</td></tr><tr><td>stomachache</td><td>-</td><td>2 (5%)</td><td>5 (14%)</td><td>7</td></tr><tr><td>excitation</td><td>9 (25%)</td><td>6 (17%)</td><td>8 (22%)</td><td>23</td></tr><tr><td>anxiety</td><td>2 (5%)</td><td>-</td><td>-</td><td>2</td></tr><tr><td>shaking hands</td><td>-</td><td>1 (3%)</td><td>4 (11%)</td><td>5</td></tr><tr><td>somnolence</td><td>-</td><td>8 (22%)</td><td>5 (14%)</td><td>13</td></tr><tr><td>malaise and others</td><td>3 (8%)</td><td>9 (25%)</td><td>10 (28%)</td><td>22</td></tr></table> |
1b35df4929f68e558c8c93d43fbb4a77ef15e05b90ad462ac07eb0b1eab321b5.png | complex | <table><tr><td> </td><td>2009</td><td>2004-08</td><td>H1N1 Attributable</td><td>Rate Ratio: 2009:2004-08</td></tr><tr><td colspan="5">British Columbia</td></tr><tr><td>First Nations Reserves</td><td>13.77</td><td>9.48</td><td>4.29</td><td>1.45</td></tr><tr><td>Other Residents</td><td>6.65</td><td>6.18</td><td>0.47</td><td>1.08</td></tr><tr><td>Rate Ratio:</td><td rowspan="2">2.07</td><td rowspan="2">1.53</td><td rowspan="2">9.13</td><td rowspan="2">1.35*</td></tr><tr><td>First Nations:Other</td></tr><tr><td colspan="5">Manitoba</td></tr><tr><td>First Nations Reserves</td><td>26.84</td><td>18.44</td><td>8.40</td><td>1.46</td></tr><tr><td>Other Residents</td><td>11.21</td><td>10.07</td><td>1.14</td><td>1.11</td></tr><tr><td>Rate Ratio:</td><td rowspan="2">2.39</td><td rowspan="2">1.83</td><td rowspan="2">7.36</td><td rowspan="2">1.31*</td></tr><tr><td>First Nations:Other</td></tr><tr><td colspan="5">Ontario</td></tr><tr><td>First Nations Reserves</td><td>16.84</td><td>11.74</td><td>5.10</td><td>1.44</td></tr><tr><td>Other Residents</td><td>7.35</td><td>5.54</td><td>1.81</td><td>1.33</td></tr><tr><td>Rate Ratio:</td><td rowspan="2">2.29</td><td rowspan="2">2.12</td><td rowspan="2">2.81</td><td rowspan="2">1.08*</td></tr><tr><td>First Nations:Other</td></tr></table> |
3d23dd5214fb5cecf3e8cd6ed693e0197401106f30e8c36110d4fb870a1d9400.png | simple | <table><tr><td>Dataset</td><td>DaliLite</td><td>TM-align</td><td>CE</td><td>MICAN</td><td>DEDAL</td><td>SNAP</td><td>GANGSTA+</td><td>SCALI</td><td>MASS</td><td>SAMO</td></tr><tr><td>MALIDUP-sq</td><td>85.3</td><td>81.0</td><td>62.3</td><td>85.8</td><td>83.4</td><td>70.8</td><td>64.4</td><td>56.2</td><td>50.4</td><td>42.8</td></tr><tr><td>MALISAM-sq</td><td>67.3</td><td>53.7</td><td>21.2</td><td>65.5</td><td>56.2</td><td>43.4</td><td>36.0</td><td>35.8</td><td>21.3</td><td>17.0</td></tr><tr><td>MALIDUP-ns</td><td>37.9</td><td>43.0</td><td>—</td><td>85.6</td><td>81.4</td><td>71.3</td><td>63.3</td><td>54.2</td><td>51.5</td><td>19.0</td></tr><tr><td>MALISAM-ns</td><td>21.7</td><td>22.5</td><td>—</td><td>67.6</td><td>56.1</td><td>43.6</td><td>29.9</td><td>37.5</td><td>20.4</td><td>8.5</td></tr></table> |
0c85fa6473b7266a435fc81971c3ea996167908c5b4d0aabe19a4ca1fcee68bb.png | complex | <table><tr><td rowspan="2">Color Choice</td><td colspan="3">Volunteer group</td><td rowspan="2">p value</td></tr><tr><td>HAD normal (n = 460) <i>No. (%) </i>Respondents</td><td>HAD anxious (n = 117) <i>No. (%) </i>Respondents</td><td>HAD depressed (n = 35) <i>No. (%) </i>Respondents</td></tr><tr><td>Positive</td><td>212 (46.1%)</td><td>39 (33.3%)</td><td>8 (22.9%)</td><td rowspan="3">Chi-square (4) = 33.656; p < 0.001</td></tr><tr><td>Neutral</td><td>175 (38.0%)</td><td>44 (37.6%)</td><td>9 (25.7%)</td></tr><tr><td>Negative</td><td>73 (15.9%)</td><td>34 (29.1%)</td><td>18 (51.4%)</td></tr></table> |
da0f451c63a024829d9d979c3e5515b1a4b043e8d0279ce0646ef6e355dfb261.png | simple | <table><tr><td>Use of CAM/conventional medicine</td><td>Frequency (%)</td></tr><tr><td>use only CAM</td><td>166 (51.1)</td></tr><tr><td>use combination of CAM and conventional medicine</td><td>159 (48.9)</td></tr><tr><td>Total</td><td>325 (100)</td></tr></table> |
c8c4e85b36b1c128aba2a3b0e5229c8accaa5c05e0caeb22f9f72f4bf7ac2a0f.png | complex | <table><tr><td rowspan="3">Variable</td><td colspan="2">Year of survey 2005</td><td colspan="2">Year of survey 2012</td><td rowspan="3">p</td></tr><tr><td>n</td><td>%</td><td>n</td><td>%</td></tr><tr><td>Toilet</td><td> </td><td> </td><td> </td><td> </td><td>< 0.001</td></tr><tr><td>Absence</td><td>169</td><td>36.5</td><td>284</td><td>34.8</td><td> </td></tr><tr><td>Ceramic</td><td>99</td><td>21.4</td><td>276</td><td>33.8</td><td> </td></tr><tr><td>Wood</td><td>195</td><td>42.1</td><td>257</td><td>31.4</td><td> </td></tr><tr><td>Total</td><td>463</td><td>100</td><td>817</td><td>100</td><td> </td></tr><tr><td>Origin of water</td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Rain</td><td>4</td><td>0.9</td><td>18</td><td>2.2</td><td>0.001</td></tr><tr><td>Public network</td><td>160</td><td>34.6</td><td>239</td><td>29.8</td><td> </td></tr><tr><td>Well or spring</td><td>76</td><td>16.4</td><td>90</td><td>11.2</td><td> </td></tr><tr><td>River</td><td>223</td><td>48.2</td><td>456</td><td>56.8</td><td> </td></tr><tr><td>Total</td><td>463</td><td>100</td><td>803</td><td>100</td><td> </td></tr><tr><td>Frequency of water shortage</td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Never</td><td>335</td><td>72.5</td><td>504</td><td>62.1</td><td>< 0.001</td></tr><tr><td>Rarely</td><td>73</td><td>15.8</td><td>166</td><td>20.4</td><td> </td></tr><tr><td>Often</td><td>54</td><td>11.7</td><td>142</td><td>17.5</td><td> </td></tr><tr><td>Total</td><td>462</td><td>100</td><td>812</td><td>100</td><td> </td></tr><tr><td>Treatment of drinking water</td><td> </td><td> </td><td> </td><td> </td><td>< 0.001*</td></tr><tr><td>Boiled/Filtered and boiled</td><td>61</td><td>13.3</td><td>48</td><td>6.1</td><td> </td></tr><tr><td>Filtered</td><td>20</td><td>4.4</td><td>32</td><td>4.1</td><td> </td></tr><tr><td>Chlorinated at home</td><td>244</td><td>53.3</td><td>449</td><td>57.5</td><td> </td></tr><tr><td>Mineral</td><td>2</td><td>0.4</td><td>9</td><td>1.2</td><td> </td></tr><tr><td>Untreated</td><td>131</td><td>28.6</td><td>243</td><td>31.1</td><td> </td></tr><tr><td>Total</td><td>458</td><td>100</td><td>781</td><td>100</td><td> </td></tr><tr><td>Destination of trash</td><td> </td><td> </td><td> </td><td> </td><td>0.675</td></tr><tr><td>Collection</td><td>168</td><td>36.4</td><td>304</td><td>38.8</td><td> </td></tr><tr><td>Buried/Burned/Thrown into river</td><td>163</td><td>35.4</td><td>273</td><td>34.8</td><td> </td></tr><tr><td>Thrown in open area</td><td>130</td><td>28.2</td><td>207</td><td>26.4</td><td> </td></tr><tr><td>Total</td><td>461</td><td>100</td><td>784</td><td>100</td><td> </td></tr><tr><td>Destination of sewage</td><td> </td><td> </td><td> </td><td> </td><td>< 0.001</td></tr><tr><td>Septic tank</td><td>65</td><td>14.2</td><td>124</td><td>15.6</td><td> </td></tr><tr><td>Cesspit</td><td>130</td><td>28.4</td><td>317</td><td>39.8</td><td> </td></tr><tr><td>Open pit</td><td>210</td><td>46.0</td><td>276</td><td>34.7</td><td> </td></tr><tr><td>Others</td><td>52</td><td>11.4</td><td>79</td><td>9.9</td><td> </td></tr><tr><td>Total</td><td>457</td><td>100</td><td>796</td><td>100</td><td> </td></tr></table> |
d6882188486d037365f9e28576b7b16cf41dccdf3d01431bf9907da556f11362.png | complex | <table><tr><td colspan="7">Cord plasma insulin</td></tr><tr><td> </td><td> </td><td colspan="2">Unadjusted analysis</td><td colspan="3">Adjusted analysis</td></tr><tr><td> </td><td>N</td><td>β</td><td>P-value</td><td>β</td><td>P-value</td><td>Adjusted model r<sup>2</sup></td></tr><tr><td>Week-1</td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>SFT</td><td>44</td><td>0.398</td><td>0.007</td><td>0.325</td><td>0.071</td><td>0.195; p = 0.026</td></tr><tr><td>SCA</td><td>36</td><td>0.464</td><td>0.004</td><td>0.390</td><td>0.039</td><td>0.310; p = 0.008</td></tr><tr><td>PPA</td><td>36</td><td>0.445</td><td>0.007</td><td>0.436</td><td>0.022</td><td>0.311; p = 0.008</td></tr><tr><td>Week-6</td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>SFT</td><td>40</td><td>0.294</td><td>0.065</td><td>0.292</td><td>0.146</td><td>0.122; p = 0.127</td></tr><tr><td>SCA</td><td>40</td><td>0.335</td><td>0.035</td><td>0.241</td><td>0.217</td><td>0.163; p = 0.074</td></tr><tr><td>PPA</td><td>40</td><td>0.307</td><td>0.054</td><td>0.287</td><td>0.119</td><td>0.268; p = 0.014</td></tr><tr><td>Month-4</td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>SFT</td><td>39</td><td>0.281</td><td>0.084</td><td>0.196</td><td>0.335</td><td>0.080; p = 0.215</td></tr><tr><td>SCA</td><td>39</td><td>0.175</td><td>0.287</td><td>0.056</td><td>0.794</td><td>−0.044; p = 0.615</td></tr><tr><td>PPA</td><td>39</td><td>0.146</td><td>0.368</td><td>0.011</td><td>0.961</td><td>−0.090; p = 0.799</td></tr><tr><td>Year-1</td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>SFT</td><td>41</td><td>−0.072</td><td>0.653</td><td>−0.017</td><td>0.937</td><td>−0.080; p = 0.769</td></tr><tr><td>SCA</td><td>41</td><td>0.027</td><td>0.866</td><td>0.085</td><td>0.680</td><td>−0.034; p = 0.585</td></tr><tr><td>PPA</td><td>41</td><td>0.062</td><td>0.698</td><td>0.198</td><td>0.290</td><td>0.137; p = 0.099</td></tr></table> |
7f0a95011e2fdc5f0009042ff0460c505e50bfa08d4138c5b12d5a00a1cb68eb.png | simple | <table><tr><td>Dam</td><td>Sire</td><td>Family</td><td>Contribution</td><td>Offspring males</td><td>Offspring females</td><td>Average weight in g (±se)</td><td>Average length in mm (±s.e)</td><td><i>P</i>-value</td></tr><tr><td>Dam 1</td><td>Sire 1</td><td>1</td><td>7.4 %</td><td>4</td><td>9</td><td>194.2 (58.7)</td><td>256.5 (20.9)</td><td>0.27</td></tr><tr><td>Dam 1</td><td>Sire 2</td><td>2</td><td>10.8 %</td><td>14</td><td>5</td><td>179.3 (34.1)</td><td>249.5 (15.3)</td><td>0.066</td></tr><tr><td>Dam 1</td><td>Sire 3</td><td>3</td><td>9.7 %</td><td>5</td><td>12</td><td>181.9 (65.2)</td><td>248.6 (31.4)</td><td>0.15</td></tr><tr><td>Dam 1</td><td>Sire 4</td><td>4</td><td>17.7 %</td><td>17</td><td>14</td><td>178.2 (48.2)</td><td>248.7 (19.9)</td><td>0.719</td></tr><tr><td>Dam 2</td><td>Sire 1</td><td>5</td><td>9.1 %</td><td>5</td><td>11</td><td>148.1 (37)</td><td>231.5 (16.1)</td><td>0.21</td></tr><tr><td>Dam 2</td><td>Sire 2</td><td>6</td><td>12.6 %</td><td>14</td><td>8</td><td>150.2 (54.9)</td><td>233.0 (26.8)</td><td>0.28</td></tr><tr><td>Dam 2</td><td>Sire 3</td><td>7</td><td>10.9 %</td><td>3</td><td>16</td><td>170.0 (67.5)</td><td>240.2 (28.3)</td><td>0.0059<sup>**</sup></td></tr><tr><td>Dam 2</td><td>Sire 4</td><td>8</td><td>21.7 %</td><td>25</td><td>13</td><td>160.5 (52.8)</td><td>239.6 (24.7)</td><td>0.074</td></tr></table> |
8c731812c7f9fdfc4d5485cba3a3ad2220a273b1b2321501d56f58be15b391d5.png | simple | <table><tr><td>RV Strain (Origin)</td><td>GenBank Accession number</td><td>P-type</td></tr><tr><td>RF (Bovine)</td><td>U65924</td><td>P[1]</td></tr><tr><td>SA11 (Simian)</td><td>M23188</td><td>P[2]</td></tr><tr><td>RRV (Simian)</td><td>M18736</td><td>P[3]</td></tr><tr><td>RV-5 (Human)</td><td>M32559</td><td>P[4]</td></tr><tr><td>UK (Bovine)</td><td>M22306</td><td>P[5]</td></tr><tr><td>Gottfried (Porcine)</td><td>M33516</td><td>P[6]</td></tr><tr><td>OSU (Porcine)</td><td>X13190</td><td>P[7]</td></tr><tr><td>Wa (Human)</td><td>M96825</td><td>P[8]</td></tr><tr><td>K8 (Human)</td><td>D90269</td><td>P[9]</td></tr><tr><td>69M (Human)</td><td>M60600</td><td>P[10]</td></tr><tr><td>B223 (Bovine)</td><td>D13394</td><td>P[11]</td></tr><tr><td>H-2 (Equine)</td><td>L04638</td><td>P[12]</td></tr><tr><td>MDR-13 (Porcine)</td><td>L07886</td><td>P[13]</td></tr><tr><td>PA169 (Human)</td><td>D14724</td><td>P[14]</td></tr><tr><td>Lp14 (Ovine)</td><td>L11599</td><td>P[15]</td></tr><tr><td>EB (Murine)</td><td>U08419</td><td>P[16]</td></tr><tr><td>993–83 (Bovine)</td><td>D16352</td><td>P[17]</td></tr><tr><td>L338 (Equine)</td><td>D13399</td><td>P[18]</td></tr><tr><td>4F (Porcine)</td><td>L10359</td><td>P[19]</td></tr><tr><td>EHP (Murine)</td><td>U08424</td><td>P[20]</td></tr><tr><td>Hg18 (Bovine)</td><td>AF237665</td><td>P[21]</td></tr><tr><td>160/01 (Lapine)</td><td>AF526374</td><td>P[22]</td></tr><tr><td>A34 (Porcine)</td><td>AY174094</td><td>P[23]</td></tr><tr><td>TUCH (rhesus macaque)</td><td>AY596189</td><td>P[24]</td></tr><tr><td>Dhaka6 (Human)</td><td>AY773004</td><td>P[25]</td></tr><tr><td>134/04 – 15 (Porcine)</td><td>DQ061053</td><td>P[26]</td></tr><tr><td>CMP034 (Porcine)</td><td>DQ534016</td><td>P[27]</td></tr></table> |
b0dc6616b1739980ecea0d6f901012ddd226864d2234b7d5d3b2ee873c3f2fe3.png | simple | <table><tr><td></td><td>All Subjects</td><td>Non-abdominal obesity group</td><td>Abdominal obesity group</td><td><i>P</i></td></tr><tr><td>n</td><td>326</td><td>163</td><td>163</td><td></td></tr><tr><td>Age, y</td><td>45.1 ± 8.1</td><td>45.3 ± 8.4</td><td>44.8 ± 7.7</td><td>n.s.</td></tr><tr><td>Waist, cm</td><td>84.8 ± 8.2</td><td>78.3 ± 4.7</td><td>91.2 ± 5.2</td><td><0.0001</td></tr><tr><td>BMI, kg/m<sup>2</sup></td><td>24.3 ± 3.3</td><td>22.1 ± 2.0</td><td>26.6 ± 2.8</td><td><0.0001</td></tr><tr><td>SBP, mmHg</td><td>123 ± 16</td><td>120 ± 14</td><td>127 ± 17</td><td><0.0001</td></tr><tr><td>DBP, mmHg</td><td>79 ± 12</td><td>76 ± 11</td><td>82 ± 13</td><td><0.0001</td></tr><tr><td>TC, mg/dl</td><td>208 ± 35</td><td>203 ± 33</td><td>214 ± 37</td><td>0.003</td></tr><tr><td>TG, mg/dl</td><td>131 ± 128</td><td>100 ± 53</td><td>162 ± 168</td><td><0.0001</td></tr><tr><td>HDL-C, mg/dl</td><td>58 ± 14</td><td>62 ± 15</td><td>53 ± 11</td><td><0.0001</td></tr><tr><td>LDL-C, mg/dl</td><td>125 ± 34</td><td>120 ± 31</td><td>129 ± 37</td><td>0.03</td></tr><tr><td>FPG, mg/dl</td><td>91 ± 10</td><td>89 ± 9</td><td>93 ± 10</td><td>0.0009</td></tr><tr><td>HOMA-IR</td><td>1.35 ± 2.03</td><td>0.75 ± 0.29</td><td>1.87 ± 2.67</td><td>0.03</td></tr><tr><td>hs-CRP, mg/L</td><td>0.68 ± 0.77</td><td>0.58 ± 0.82</td><td>0.78 ± 0.71</td><td>0.018</td></tr><tr><td>IL-6, pg/ml</td><td>1.26 ± 0.75</td><td>1.18 ± 0.66</td><td>1.34 ± 0.83</td><td>0.045</td></tr><tr><td>Adiponectin, μg/ml</td><td>6.3 ± 2.9</td><td>7.1 ± 3.3</td><td>5.5 ± 2.1</td><td>< 0.0001</td></tr></table> |
2fde017285e9cfc549986761dd4da62b16fb8f0ed31c7ca33910aaa4f032736f.png | simple | <table><tr><td></td><td>Conditioned taste aversion</td><td>Passive avoidance</td><td>Morris water maze 19°C</td><td>Morris water maze 23°C</td><td>Object recognition</td><td>Object location</td></tr><tr><td>Consolidation</td><td>No effect</td><td>No effect</td><td>No effect</td><td>No effect</td><td>Effect</td><td>Effect</td></tr><tr><td>Reconsolidation</td><td>Effect</td><td>Effect</td><td>No effect</td><td>No effect</td><td>Effect</td><td>Effect</td></tr><tr><td>Aversive task</td><td>+++</td><td>+++</td><td>++</td><td>+</td><td>0</td><td>0</td></tr><tr><td>Spatial task</td><td>No</td><td>No</td><td>Yes</td><td>Yes</td><td>No</td><td>Yes</td></tr><tr><td>Associative task</td><td>Yes</td><td>Yes</td><td>Yes</td><td>Yes</td><td>No</td><td>No</td></tr></table> |
1d5bf653afc076112b1ec8897f10015429570eec6fafb5ff5bb266bb3965695c.png | simple | <table><tr><td></td><td>n</td><td>Mean age ± SD</td><td>T/S ratio ± SD</td><td>p*</td></tr><tr><td>OA patients</td><td>79</td><td>69.46 ± 8.97</td><td>0.986 ± 0.261</td><td>0.684</td></tr><tr><td>Healthy controls</td><td>166</td><td>51.92 ± 18.45</td><td>1.008 ± 0.287</td><td></td></tr><tr><td>Haplogroup J</td><td>155</td><td>52.97 ± 17.60</td><td>1.039 ± 0.287</td><td>0.003**</td></tr><tr><td>Non-J</td><td>90</td><td>65.22 ± 15.98</td><td>0.933 ± 0.254</td><td></td></tr></table> |
d5d053fd07e7caba8a9ed16ab378cc6122c047249106c243eaaa6fd23435f99b.png | simple | <table><tr><td> </td><td>N</td><td>Mean</td><td> </td><td>Increase</td></tr><tr><td>Age</td><td>(studies)</td><td>rate (%)<sup>†</sup></td><td>(95% CI)</td><td>of rates<sup>‡</sup></td></tr><tr><td>65-69</td><td>17</td><td>1.2</td><td>(0.8-1.5)</td><td> </td></tr><tr><td>70-74</td><td>19</td><td>3.7</td><td>(2.6-4.7)</td><td>3.0</td></tr><tr><td>75-79</td><td>21</td><td>7.9</td><td>(6.2-9.5)</td><td>2.1</td></tr><tr><td>80-84</td><td>20</td><td>16.4</td><td>(13.8-18.9)</td><td>2.0</td></tr><tr><td>85-89</td><td>16</td><td>24.6</td><td>(20.5-28.6)</td><td>1.5</td></tr><tr><td>90-94</td><td>6</td><td>39.9</td><td>(34.4-45.3)</td><td>1.6</td></tr><tr><td>>95</td><td>6</td><td>54.8</td><td>(45.6-63.9)</td><td>1.3</td></tr></table> |
b85c6feea7060f2198373dd47f61c2a138e6fd1a0fdf61285227734bcadcf635.png | complex | <table><tr><td>Week</td><td colspan="2">Content and homework</td></tr><tr><td>1</td><td>Browser:</td><td>Psychoeducation:</td></tr><tr><td colspan="2"></td><td>Information about panic</td></tr><tr><td colspan="2"></td><td>Defining goals of training</td></tr><tr><td colspan="2"></td><td>Setting up a reward list</td></tr><tr><td></td><td>Mobile:</td><td>Daily diary</td></tr><tr><td colspan="2"></td><td>Registration of current panic event (event-based)</td></tr><tr><td colspan="2"></td><td>Daily summary of panic, avoidance, and mood</td></tr><tr><td>2</td><td>Browser:</td><td>Interoceptive exposure:</td></tr><tr><td colspan="2"></td><td>Bodily symptoms in panic</td></tr><tr><td colspan="2"></td><td>Avoidance</td></tr><tr><td colspan="2"></td><td>Safety behaviors</td></tr><tr><td></td><td>Mobile:</td><td>Respiratory interoceptive exposure exercises</td></tr><tr><td colspan="2"></td><td>Daily diary</td></tr><tr><td>3</td><td>Browser:</td><td><i>In vivo</i> exposure:</td></tr><tr><td colspan="2"></td><td>Defining an anxiety hierarchy</td></tr><tr><td></td><td>Mobile:</td><td><i>In vivo</i> exposures</td></tr><tr><td colspan="2"></td><td>Dizziness interoceptive exposure exercises</td></tr><tr><td colspan="2"></td><td>Daily diary</td></tr><tr><td>4</td><td>Browser:</td><td>Cognitive restructuring I:</td></tr><tr><td colspan="2"></td><td>Negative automatic thoughts</td></tr><tr><td colspan="2"></td><td>Defining anxiety project (training schedule for exposures)</td></tr><tr><td></td><td>Mobile:</td><td><i>In vivo</i> exposures</td></tr><tr><td colspan="2"></td><td>Further interoceptive exposure exercises</td></tr><tr><td colspan="2"></td><td>Daily diary</td></tr><tr><td>5</td><td>Browser:</td><td>Cognitive restructuring II:</td></tr><tr><td colspan="2"></td><td>Reality testing of automatic negative thoughts</td></tr><tr><td></td><td>Mobile:</td><td><i>In vivo</i> exposures</td></tr><tr><td colspan="2"></td><td>Further interoceptive exposure exercises</td></tr><tr><td colspan="2"></td><td>Daily diary</td></tr><tr><td>6</td><td>Browser:</td><td>Relapse prevention:</td></tr><tr><td colspan="2"></td><td>Early warning signs</td></tr><tr><td colspan="2"></td><td>Critical life events</td></tr><tr><td colspan="2"></td><td>Evaluation of training and its aims</td></tr><tr><td></td><td>Mobile:</td><td>Breathing and muscle relaxation exercises</td></tr></table> |
5fba50cf2e6c66b53052b805e8017e5190bd8f1d710504436719b4dea7ec5865.png | complex | <table><tr><td rowspan="2"></td><td rowspan="2">n</td><td colspan="3">Time to go to sleep n (%)</td></tr><tr><td>Before 19:00</td><td>Between 19:00 and 21:00</td><td>Later</td></tr><tr><td colspan="5">Age group (years)</td></tr><tr><td> < 5</td><td>49</td><td>4 (8.2)</td><td>40 (88.9)</td><td>5 (11.1)</td></tr><tr><td> 5–15</td><td>123</td><td>–</td><td>85 (69.1)</td><td>38 (30.9)</td></tr><tr><td> 16–49</td><td>146</td><td>–</td><td>69 (47.3)</td><td>77 (52.7)</td></tr><tr><td> > 49</td><td>27</td><td>–</td><td>10 (37.0)</td><td>17 (63.0)</td></tr><tr><td>Total</td><td>341</td><td>4 (1.2)</td><td>204 (59.8)</td><td>137 (40.2)</td></tr></table> |
e22a156d6840dc3e5b213463fb035b2d637bde2cd1f87b1425373ba5edba345d.png | complex | <table><tr><td></td><td>F</td><td>d.f.</td><td>P</td></tr><tr><td colspan="4">Size increase</td></tr><tr><td> Sex</td><td>4.95</td><td>1, 697</td><td>0.03</td></tr><tr><td> Treatment</td><td>0.20</td><td>1, 697</td><td>0.65</td></tr><tr><td> Sex × Treatment</td><td>0.60</td><td>1, 697</td><td>0.44</td></tr><tr><td colspan="4">Weight increase</td></tr><tr><td> Sex</td><td>4.95</td><td>1, 697</td><td>0.02</td></tr><tr><td> Treatment</td><td>0.20</td><td>1, 697</td><td>0.65</td></tr><tr><td> Sex × Treatment</td><td>0.60</td><td>1, 697</td><td>0.44</td></tr><tr><td colspan="4">Development rate</td></tr><tr><td> Sex</td><td>41.13</td><td>1, 697</td><td><0.0001</td></tr><tr><td> Treatment</td><td>6.46</td><td>1, 697</td><td>0.01</td></tr><tr><td> Sex × Treatment</td><td>1.19</td><td>1, 697</td><td>0.28</td></tr><tr><td colspan="4">Lifespan</td></tr><tr><td> Sex</td><td>22.55</td><td>1, 697</td><td><0.0001</td></tr><tr><td> Treatment</td><td>0.24</td><td>1, 697</td><td>0.62</td></tr><tr><td> Sex × Treatment</td><td>6.76</td><td>1, 697</td><td>0.009</td></tr></table> |
eb218d2465a15c7c1b771dd8995e65ea47581a21f0c9c4bbde22ed86f0e2e53e.png | simple | <table><tr><td>Tissue</td><td>Time (Months)</td><td>Control</td><td>Salmon b</td><td>Aimara c</td></tr><tr><td>Hair</td><td>3</td><td>3.4 ± 1.2</td><td>6.5 ± 2</td><td>242 ± 11 <sup>*</sup></td></tr><tr><td></td><td>14</td><td>33 ± 26</td><td>30 ± 8</td><td>733 ± 201 <sup>*</sup></td></tr><tr><td>Kidney</td><td>3</td><td>12 ± 3</td><td>16 ± 2</td><td>359 ± 200 <sup>*</sup></td></tr><tr><td></td><td>14</td><td>7 ± 2</td><td>21 ± 2 °</td><td>511 ± 1034 <sup>*</sup></td></tr><tr><td>Liver</td><td>3</td><td>4.8 ± 0.4</td><td>4.5 ± 1.2</td><td>34 ± 18 <sup>*</sup></td></tr><tr><td></td><td>14</td><td>4 ± 2.6</td><td>7.7 ± 1.4</td><td>77 ± 11 <sup>*</sup></td></tr><tr><td>Muscles</td><td>3</td><td>6 ± 2</td><td>6 ± 2</td><td>34 ± 18 <sup>*</sup></td></tr><tr><td></td><td>14</td><td>8 ± 8</td><td>13 ± 2</td><td>53 ± 11 <sup>*</sup></td></tr><tr><td>Brain</td><td>3</td><td>9 ± 2</td><td>9 ± 2</td><td>23 ± 5 <sup>*</sup></td></tr><tr><td>Hippocampus</td><td>14</td><td>4 ± 5</td><td>11 ± 7</td><td>46 ± 4 <sup>*</sup></td></tr><tr><td>Cortex</td><td>14</td><td>1.5 ± 0.4</td><td>11 ± 7</td><td>35 ± 3 <sup>*</sup></td></tr><tr><td>Striatum</td><td>14</td><td>3 ± 3</td><td>11 ± 7</td><td>56 ± 11 <sup>*</sup></td></tr><tr><td>Eyes</td><td>14</td><td>3 ± 2</td><td>18 ± 5 °</td><td>61 ± 24 <sup>*</sup></td></tr><tr><td>Lung</td><td>14</td><td>8 ± 4</td><td>9 ± 2</td><td>74 ± 7 <sup>*</sup></td></tr><tr><td>Intestines</td><td>14</td><td>12 ± 11</td><td>4.1 ± 0.3</td><td>48 ± 9 <sup>*</sup></td></tr><tr><td>Heart</td><td>14</td><td>4 ± 3</td><td>7 ± 4</td><td>43 ± 9 <sup>*</sup></td></tr><tr><td>Spleen</td><td>14</td><td>9 ± 3</td><td>18 ± 11</td><td>45 ± 3 <sup>*</sup></td></tr><tr><td>Skin</td><td>14</td><td>18 ± 12</td><td>7 ± 4</td><td>24 ± 5 <sup>*</sup></td></tr><tr><td>Blood</td><td>14</td><td>6.4 ± 0.1</td><td>7.2 ± 0.1</td><td>27.7 ± 2.5 <sup>*</sup></td></tr><tr><td>Feces</td><td>14</td><td>6.5 ± 0.3</td><td>6.5 ± 1.1</td><td>34.8 ± 1.4 <sup>*</sup></td></tr></table> |
62a2ffa74587e400852c5d020adb05208b7f0a3ef0e3892985e5ddccbfa67e63.png | simple | <table><tr><td>Term</td><td>Prime number</td><td>Relation</td><td>Modified Gödel Number</td></tr><tr><td>Term1</td><td>2</td><td></td><td></td></tr><tr><td>Term2</td><td>3</td><td>R1: Term2 is a Term1</td><td>relation(is a) = 3 × 2 = 6</td></tr><tr><td>Term3</td><td>5</td><td>R2: Term3 is part of Term2</td><td>relation(part of) = 5 × 3 × 2 = 30</td></tr><tr><td>Term4</td><td>7</td><td>R3: Term4 is a Term2</td><td>relation(is a) = 7 × 3 × 2 = 42</td></tr></table> |
dada9064195a0e132e4e634c7c9fce97cce266f3468d8930b5782fb7dfa9db35.png | complex | <table><tr><td>Table 3</td><td colspan="2">All grades</td><td colspan="2">Grade 3</td></tr><tr><td></td><td>n</td><td>%</td><td>n</td><td>%</td></tr><tr><td>Skin</td><td>5</td><td>19</td><td>1</td><td>4</td></tr><tr><td>Lymph edema</td><td>3</td><td>12</td><td></td><td></td></tr><tr><td>Dysphagia</td><td>2</td><td>8</td><td>1</td><td>4</td></tr><tr><td>Xerostomia</td><td>8</td><td>31</td><td></td><td></td></tr><tr><td>Loss of taste</td><td>4</td><td>15</td><td></td><td></td></tr><tr><td>Hearing loss</td><td>3</td><td>12</td><td>2</td><td>8</td></tr><tr><td>Sinusitis</td><td>1</td><td>4</td><td>1</td><td>4</td></tr><tr><td>Hypothyreosis</td><td>1</td><td>4</td><td></td><td></td></tr><tr><td>Hoarseness</td><td>1</td><td>4</td><td></td><td></td></tr><tr><td>Dry eye</td><td>1</td><td>4</td><td></td><td></td></tr><tr><td>Skin infection*</td><td>1</td><td>4</td><td>1</td><td>4</td></tr><tr><td>Trismus</td><td>1</td><td>4</td><td></td><td></td></tr></table> |
7ce6d8f5c2c7d55bfc8fdb8ec61d3b145bb7522a356b9be83f9cef82ddfa793b.png | complex | <table><tr><td></td><td colspan="2">Health facility providers</td><td colspan="2">Pharmacists</td><td colspan="2">PMV operators</td></tr><tr><td>Minimum age</td><td>n</td><td>%</td><td>n</td><td>%</td><td>n</td><td>%</td></tr><tr><td> Male condom</td><td>692</td><td>73.1</td><td>410</td><td>76.3</td><td>474</td><td>70.7</td></tr><tr><td> Pill</td><td>906</td><td>86.9**</td><td>318</td><td>81.8</td><td>313</td><td>79.9</td></tr><tr><td> EC</td><td>395</td><td>70.1***</td><td>292</td><td>82.9</td><td>183</td><td>75.4</td></tr><tr><td> Injectable</td><td>1071</td><td>88.5*</td><td>289</td><td>84.1</td><td>na</td><td>na</td></tr><tr><td> IUD</td><td>560</td><td>93.2</td><td>na</td><td>na</td><td>na</td><td>na</td></tr><tr><td colspan="7">Minimum parity</td></tr><tr><td> Male condom</td><td>692</td><td>3.0*</td><td>410</td><td>2.9</td><td>474</td><td>5.7</td></tr><tr><td> Pill</td><td>906</td><td>38.3***</td><td>318</td><td>28.9</td><td>313</td><td>43.5</td></tr><tr><td> EC</td><td>395</td><td>12.7*</td><td>292</td><td>12.3</td><td>183</td><td>20.2</td></tr><tr><td> Injectable</td><td>1071</td><td>64.7***</td><td>289</td><td>21.8</td><td>na</td><td>na</td></tr><tr><td> IUD</td><td>560</td><td>53.4</td><td>na</td><td>na</td><td>na</td><td>na</td></tr><tr><td colspan="7">Marital status</td></tr><tr><td> Male condom</td><td>692</td><td>10.4</td><td>410</td><td>9.5</td><td>474</td><td>7.2</td></tr><tr><td> Pill</td><td>906</td><td>51.3***</td><td>318</td><td>41.5</td><td>313</td><td>57.5</td></tr><tr><td> EC</td><td>395</td><td>16.7**</td><td>292</td><td>26.4</td><td>183</td><td>23.5</td></tr><tr><td> Injectable</td><td>1071</td><td>73.5***</td><td>289</td><td>45.3</td><td>na</td><td>na</td></tr><tr><td> IUD</td><td>560</td><td>67.3</td><td>na</td><td>na</td><td>na</td><td>na</td></tr><tr><td colspan="7">Overall bias score</td></tr><tr><td> Male condom</td><td>692</td><td>0.9</td><td>410</td><td>0.9</td><td>474</td><td>0.8</td></tr><tr><td> Pill</td><td>906</td><td>1.8***</td><td>318</td><td>1.5</td><td>313</td><td>1.8</td></tr><tr><td> EC</td><td>395</td><td>1.0***</td><td>292</td><td>1.2</td><td>183</td><td>1.2</td></tr><tr><td> Injectable</td><td>1071</td><td>2.3***</td><td>289</td><td>1.5</td><td>na</td><td>na</td></tr><tr><td> IUD</td><td>560</td><td>2.1</td><td>na</td><td>na</td><td>na</td><td>na</td></tr><tr><td>Total<sup>a</sup></td><td></td><td>3.7</td><td></td><td>3.6</td><td></td><td>3.8</td></tr></table> |
ec43243f7376d043f5df215d27e85492748ee92626fb20de97a8abe6ccfe67ed.png | simple | <table><tr><td> </td><td>Unadjusted OR (95% CI)</td><td>Adjusted OR (95% CI)*</td><td>Pv</td></tr><tr><td>Hillel Yaffe Medical Center vs. Carmel Medical Center</td><td>3.20 (1.53-6.69)</td><td>4.42 (1.70-11.46)</td><td>0.002</td></tr><tr><td>Arabs vs. Jews</td><td>2.30 (1.16-4.54)</td><td>2.32 (0.99-5.45)</td><td>0.05</td></tr><tr><td>Blood in the stool (yes vs. no)</td><td>1.98 (1.00-3.91)</td><td>2.78 (1.17-6.60)</td><td>0.021</td></tr><tr><td>Diarrhea (yes vs. no)</td><td>0.34 (0.11-1.03)</td><td>0.22 (0.05-1.1)</td><td>0.06</td></tr></table> |
15514cc5a90695564bef791910882fa77a93a3398af8070946b7d3eb44a95aa3.png | simple | <table><tr><td>S.n</td><td>Criterion</td><td>Sensitivity</td><td>Specificity</td><td>PPV</td><td>NPV</td></tr><tr><td>1.</td><td>Size > 6 cm</td><td>0.95</td><td>0.57</td><td>0.67</td><td>0.93</td></tr><tr><td>2.</td><td>Size >8 cm</td><td>0.75</td><td>0.76</td><td>0.75</td><td>0.76</td></tr><tr><td>3.</td><td>Shape: irregular, lobulated</td><td>0.83</td><td>0.76</td><td>0.76</td><td>0.83</td></tr><tr><td>4.</td><td>Margins: infiltrative</td><td>0.91</td><td>0.65</td><td>0.70</td><td>0.89</td></tr><tr><td>5.</td><td>Isointensity on T1W</td><td>0.70</td><td>0.76</td><td>0.73</td><td>0.74</td></tr><tr><td>6.</td><td>Slight hyperintensity on T2W</td><td>0.95</td><td>0.38</td><td>0.58</td><td>0.90</td></tr><tr><td>7.</td><td>heterogeneous lesion</td><td>1</td><td>0.5</td><td>0.64</td><td>1</td></tr><tr><td>8.</td><td>Peritumoral edema</td><td>0.95</td><td>0.5</td><td>0.63</td><td>0.92</td></tr><tr><td>9.</td><td>Absence of multiplicity</td><td>0.54</td><td>0.15</td><td>0.37</td><td>0.26</td></tr><tr><td>10.</td><td>Intratumoral necrosis</td><td>0.87</td><td>0.84</td><td>0.84</td><td>0.88</td></tr><tr><td>11.</td><td>Intratumoral hemorrhage</td><td>0.70</td><td>0.65</td><td>0.65</td><td>0.70</td></tr><tr><td>12.</td><td>Intratumoral calcification</td><td>0.70</td><td>0.88</td><td>0.85</td><td>0.76</td></tr><tr><td>13.</td><td>Absence of Intratumoral fat</td><td>1</td><td>0.07</td><td>0.5</td><td>1</td></tr><tr><td>14.</td><td>Absence of Intratumoral fibrosis</td><td>0.87</td><td>0.03</td><td>0.45</td><td>0.25</td></tr><tr><td>15.</td><td>Fascia penetration</td><td>0.83</td><td>0.73</td><td>0.82</td><td>0.74</td></tr><tr><td>16.</td><td>Bone changes</td><td>0.83</td><td>0.84</td><td>0.83</td><td>0.84</td></tr><tr><td>17.</td><td>Neurovascular involvement</td><td>0.83</td><td>0.88</td><td>0.86</td><td>0.85</td></tr><tr><td>18.</td><td>Enhancement pattern (Heterogenous)</td><td>1</td><td>0.07</td><td>0.5</td><td>1</td></tr><tr><td>19.</td><td>Absence of T1 hyperintense tracts</td><td>1</td><td>0.11</td><td>0.51</td><td>1</td></tr><tr><td>20.</td><td>Absence of Fluid-fluid levels</td><td>0.83</td><td>0.26</td><td>0.51</td><td>0.63</td></tr></table> |
56d9461a4b90fd8a153f0addb9928beb7d31da003e4ff482aeb64a583a82c315.png | simple | <table><tr><td></td><td>patients</td><td>EMD</td><td><i>p</i>*</td></tr><tr><td>pCR</td><td></td><td></td><td></td></tr><tr><td>pCR</td><td>19 (17.1)</td><td>6.1 ± 1.8</td><td>0.033</td></tr><tr><td>non-pCR</td><td>92 (82.9)</td><td>7.8 ± 3.2</td><td></td></tr><tr><td>TRG</td><td></td><td></td><td></td></tr><tr><td>TRG 0–1</td><td>50 (45.0)</td><td>7.2 ± 3.1</td><td>0.355</td></tr><tr><td>TRG 2–3</td><td>61 (55.0)</td><td>7.7 ± 3.1</td><td></td></tr><tr><td>Downstaging</td><td></td><td></td><td></td></tr><tr><td>ypStage 0–I</td><td>42 (37.8)</td><td>7.1 ± 3.0</td><td>0.258</td></tr><tr><td>ypStage II–III</td><td>69 (62.2)</td><td>7.8 ± 3.1</td><td></td></tr></table> |
610213039934f2d2fc254baf8f245a05b773f131decc82ae966a15a39fcd1407.png | complex | <table><tr><td rowspan="2">Scales</td><td rowspan="2">PANSS</td><td rowspan="2">AIMS</td><td rowspan="2">BAS</td><td rowspan="2">SAS</td><td>AP (mg)</td><td>DUI</td><td>AGE</td><td>Subtype</td><td rowspan="2">Calgary</td></tr><tr><td>(CPZ equiv.)</td><td>(years)</td><td>(years)</td><td>(<i>n</i>)</td></tr><tr><td>Groups Control (<i>n</i> = 9)</td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td>36.1/ </td><td> </td><td> </td></tr><tr><td><i>m</i>/sd</td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td>8.43 </td><td> </td><td> </td></tr><tr><td>Total (<i>n</i> = 11) </td><td>74.09/ </td><td>7.36/ </td><td>1.18/ </td><td>1.27/ </td><td>638.84/ </td><td>17.27/ </td><td>42.09</td><td>Paranoid (3)</td><td>5.55 ± 2.8</td></tr><tr><td><i>m</i>/sd </td><td>15.06</td><td>5.78 </td><td>1.17 </td><td>1.19 </td><td>439.90 </td><td>12.16 </td><td>13.67 </td><td>Undiffer. (8) </td><td> </td></tr><tr><td>CA (<i>n</i> = 6) </td><td>73.83/ </td><td>10.67/ </td><td>1.83/ </td><td>1.33/ </td><td>700.00/ </td><td>22.50/ </td><td>49.50/</td><td>Paranoid (1) </td><td>4.83 ± 3.31</td></tr><tr><td><i>m</i>/sd </td><td>17.53 </td><td>5.96 </td><td>1.17 </td><td>1.51 </td><td>496.5 </td><td>12.63 </td><td>12.45 </td><td>Undiffer. (5)</td><td> </td></tr><tr><td>AA (<i>N</i> = 5) </td><td>74.40/ </td><td>3.40/ </td><td>0.40/ </td><td>1.20/ </td><td>565.45/ </td><td>11.00/ </td><td>33.20/</td><td>Paranoid (2) </td><td>6.40 ± 2.07</td></tr><tr><td><i>m</i>/sd </td><td>13.51 </td><td>1.82 </td><td>0.55 </td><td>0.84 </td><td>404.03 </td><td>8.94 </td><td>9.60 </td><td>Undiffer. (3)</td><td> </td></tr><tr><td colspan="10">Analysis between users of CA and AA (Mann-Whitney test)</td></tr><tr><td><i>U</i> test </td><td> 14.5 </td><td>4.5 </td><td>4.5 </td><td>13 </td><td>11 </td><td>5.5 </td><td>4</td><td> </td><td>8</td></tr><tr><td><i>P</i> value</td><td>0.93 </td><td>0.05 </td><td>0.05 </td><td>0.93 </td><td>0.54 </td><td>0.08 </td><td>0.05</td><td> </td><td> 0.25</td></tr><tr><td colspan="10">Analysis between controls, AA, and CA (Kruskal-Wallis test)</td></tr><tr><td>Chi-square</td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td>5.94</td><td> </td><td> </td></tr><tr><td><i>P</i>-value</td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td>0.051</td><td> </td><td> </td></tr></table> |
a65b3fa78de4a08040ebc7663de77b89fc1becdccd080b415282ed9c96c0eb9a.png | complex | <table><tr><td> </td><td> </td><td colspan="3">Prevalence of TT post-intervention (cases per 1000 persons)</td><td colspan="3">Incidence of CO post-intervention (cases per 10,000 persons per annum)</td></tr><tr><td>Intervention</td><td>Intensity of control effort</td><td>5 years</td><td>10 years</td><td>20 years</td><td>5 years</td><td>10 years</td><td>20 years</td></tr><tr><td>S</td><td>Low</td><td>9.4</td><td>7.4</td><td>6.3</td><td>3.3</td><td>2.6</td><td>2.1</td></tr><tr><td> </td><td>Medium</td><td>3.9</td><td>3.9</td><td>3.9</td><td>1.3</td><td>1.3</td><td>1.3</td></tr><tr><td> </td><td>High</td><td>1.8</td><td>1.8</td><td>1.8</td><td>0.6</td><td>0.6</td><td>0.6</td></tr><tr><td>A</td><td>Low</td><td>13.5</td><td>13.6</td><td>13.6</td><td>4.6</td><td>4.6</td><td>4.6</td></tr><tr><td> </td><td>Medium</td><td>12.8</td><td>13.0</td><td>13.1</td><td>4.3</td><td>4.4</td><td>4.4</td></tr><tr><td> </td><td>High</td><td>12.8</td><td>12.3</td><td>12.5</td><td>4.3</td><td>4.2</td><td>4.2</td></tr><tr><td>TR</td><td>Low</td><td>13.6</td><td>12.6</td><td>9.1</td><td>4.6</td><td>4.3</td><td>3.1</td></tr><tr><td> </td><td>Medium</td><td>13.4</td><td>11.9</td><td>6.8</td><td>4.6</td><td>4.1</td><td>2.4</td></tr><tr><td> </td><td>High</td><td>12.8</td><td>9.7</td><td>4.5</td><td>4.4</td><td>3.4</td><td>1.6</td></tr><tr><td>S + A</td><td>Low</td><td>9.1</td><td>7.2</td><td>6.2</td><td>3.2</td><td>2.5</td><td>2.1</td></tr><tr><td> </td><td>Medium</td><td>3.1</td><td>3.6</td><td>3.6</td><td>1.1</td><td>1.2</td><td>1.2</td></tr><tr><td> </td><td>High</td><td>1.4</td><td>1.6</td><td>1.7</td><td>0.5</td><td>0.5</td><td>0.6</td></tr><tr><td>S + TR</td><td>Low</td><td>9.1</td><td>6.4</td><td>3.1</td><td>3.2</td><td>2.2</td><td>1.1</td></tr><tr><td> </td><td>Medium</td><td>3.4</td><td>2.6</td><td>0.6</td><td>1.2</td><td>0.9</td><td>0.2</td></tr><tr><td> </td><td>High</td><td>0.6</td><td>0.3</td><td>0.2</td><td>0.4</td><td>0.1</td><td>0.1</td></tr><tr><td>A + TR</td><td>Low</td><td>13.6</td><td>12.6</td><td>9.1</td><td>4.6</td><td>4.3</td><td>3.1</td></tr><tr><td> </td><td>Medium</td><td>13.4</td><td>11.6</td><td>6.2</td><td>4.6</td><td>4.0</td><td>2.2</td></tr><tr><td> </td><td>High</td><td>12.8</td><td>9.1</td><td>4.1</td><td>4.4</td><td>3.2</td><td>1.4</td></tr><tr><td>S + A + TR</td><td>Low</td><td>9.1</td><td>6.4</td><td>3.1</td><td>3.2</td><td>2.2</td><td>1.1</td></tr><tr><td> </td><td>Medium</td><td>3.4</td><td>1.2</td><td>0.5</td><td>1.2</td><td>0.9</td><td>0.2</td></tr><tr><td> </td><td>Hi</td><td>1.2</td><td>0.1</td><td>0.1</td><td>0.4</td><td>0.1</td><td>0.1</td></tr><tr><td>None</td><td> </td><td>14.0</td><td>14.0</td><td>14.0</td><td>4.7</td><td>4.7</td><td>4.7</td></tr></table> |
2d9b0ad3980b6a2ad76e0311007918cc941d386e04fcfa387ccbbd4e37d50e10.png | complex | <table><tr><td></td><td colspan="3">WCO</td><td colspan="3">BEO</td></tr><tr><td></td><td>Searches</td><td>Avg.</td><td>Searches</td><td>Searches</td><td>Avg.</td><td>Searches</td></tr><tr><td></td><td></td><td>Time (s)</td><td>per s</td><td></td><td>Time (s)</td><td>per s</td></tr><tr><td>LS</td><td>879</td><td>0.095</td><td>9253</td><td>2032</td><td>0.1317</td><td>15429</td></tr><tr><td>GACT</td><td>146430</td><td>4.32</td><td>33896</td><td>30850</td><td>1.01</td><td>30433</td></tr><tr><td>HC</td><td>300650</td><td>13.82</td><td>21749</td><td>299580</td><td>11.41</td><td>26256</td></tr></table> |
ebd5020e58826f60ed8b99d6a93e4393fdcbfc06aed6ac48a75dcf4e12f07273.png | simple | <table><tr><td>miRNA</td><td>*activated vs resting</td><td><i>Q</i> value</td></tr><tr><td><i>mir-211</i></td><td>Down</td><td>0.0026</td></tr><tr><td><i>miR-148a</i></td><td>Up</td><td>0.0340</td></tr><tr><td><i>mir-141</i></td><td>Down</td><td>0.0445</td></tr><tr><td><i>miR-155</i></td><td>Up</td><td>0.0445</td></tr><tr><td><i>mir-184</i></td><td>Down</td><td>0.0445</td></tr><tr><td><i>miR-15b</i></td><td>Up</td><td>0.0445</td></tr><tr><td><i>mir-30b</i></td><td>Down</td><td>0.0445</td></tr><tr><td><i>miR-150</i></td><td>Down</td><td>0.0445</td></tr><tr><td><i>miR-148b</i></td><td>Up</td><td>0.0445</td></tr><tr><td><i>mir-16-2</i></td><td>Up</td><td>0.0445</td></tr><tr><td><i>miR-216</i></td><td>Down</td><td>0.0445</td></tr><tr><td><i>mir-185</i></td><td>Down</td><td>0.0445</td></tr><tr><td><i>miR-18a</i></td><td>Up</td><td>0.0445</td></tr><tr><td><i>miR-17-5p</i></td><td>Up</td><td>0.0448</td></tr><tr><td><i>miR-130b</i></td><td>Up</td><td>0.0448</td></tr><tr><td><i>miR-516-3p</i></td><td>Down</td><td>0.0448</td></tr><tr><td><i>miR-106a</i></td><td>Up</td><td>0.0500</td></tr><tr><td><i>miR-21</i></td><td>Up</td><td>0.0500</td></tr><tr><td><i>miR-95</i></td><td>Down</td><td>0.0551</td></tr><tr><td><i>miR-20b</i></td><td>Up</td><td>0.0833</td></tr><tr><td><i>miR-425-5p</i></td><td>Up</td><td>0.0833</td></tr><tr><td><i>miR-181b</i></td><td>Up</td><td>0.0833</td></tr><tr><td><i>miR-181a</i></td><td>Up</td><td>0.0833</td></tr><tr><td><i>miR-135a</i></td><td>Down</td><td>0.0833</td></tr><tr><td><i>miR-181c</i></td><td>Up</td><td>0.0853</td></tr><tr><td><i>mir-203</i></td><td>Down</td><td>0.0855</td></tr><tr><td><i>miR-15a</i></td><td>Up</td><td>0.0855</td></tr><tr><td><i>miR-483</i></td><td>Down</td><td>0.0855</td></tr><tr><td><i>miR-182</i>*</td><td>Down</td><td>0.0855</td></tr><tr><td><i>miR-20a</i></td><td>Up</td><td>0.0855</td></tr><tr><td><i>miR-181d</i></td><td>Up</td><td>0.0909</td></tr><tr><td><i>miR-98</i></td><td>Up</td><td>0.0911</td></tr><tr><td><i>mir-326</i></td><td>Down</td><td>0.0986</td></tr></table> |
96eb85e26ea45e55c096cb77730de361060a2e80f6694b5abe9faf26e84f00cf.png | simple | <table><tr><td>Health outcome</td><td>Studies exploring associations with weather/climate</td><td>Studies projecting the health impacts of climate change</td></tr><tr><td>Heat waves</td><td>++</td><td>+</td></tr><tr><td>Other extreme events</td><td>+</td><td>0</td></tr><tr><td>Waterborne and foodborne diseases</td><td>++</td><td>0</td></tr><tr><td>Vectorborne and zoonotic diseases</td><td>+</td><td>0</td></tr><tr><td>Air pollution (limited areas)</td><td>++</td><td>+</td></tr><tr><td>Aeroallergens</td><td>+</td><td>0</td></tr><tr><td>Other health impacts including mental health, nutritional issues related to food security, and population displacement</td><td>+</td><td>0</td></tr></table> |
2966ba1d6512c72e3bfe2b2b20c96799a96bd42e3f309ece5821be75ed68e3f8.png | simple | <table><tr><td> </td><td>First assessment, first test (n = 63)</td><td>First assessment, second test (n = 63)</td><td>P-value for group difference†</td><td>Second assessment, first test (n = 61)</td><td>Second assessment, second test (n = 61)</td><td>P-value for group difference†</td></tr><tr><td>Neck flexor muscle endurance test (supine), holding time, sec</td><td>36.40 (33.25)</td><td>30.92 (25.92)</td><td>0.305</td><td>34.03 (23.74)</td><td>38.10 (33.94)</td><td>0.445</td></tr><tr><td>Neck flexor muscle endurance test (sitting 45°), holding time, sec</td><td>82.33 (57.23)</td><td>72.70 (52.83)</td><td>0.328</td><td>102.11 (82.34)</td><td>85.13 (57.81)</td><td>0.190</td></tr><tr><td>Neck extensor test, holding time, sec</td><td>36.21 (25.09)</td><td>33.51 (23.56)</td><td>0.535</td><td>37.02 (28.39)</td><td>38.34 (25.72)</td><td>0.787</td></tr></table> |
4de3e8a14ee658177fc30eea46ee1434fcc6cc8a3f67b690de198851f4a48a22.png | simple | <table><tr><td>Parameters</td><td>Soda Wheat Straw BL <sup>1</sup></td><td>Soda Barley Straw BL <sup>1</sup></td><td>Soda-AQ <sup>3</sup><i>Leucaena</i> BL <sup>1</sup></td><td>Soda-AQ <sup>3</sup><i>Chamaecytisus</i> BL <sup>1</sup></td></tr><tr><td>pH</td><td>10.72 ± 0.16</td><td>10.24 ± 0.011</td><td>9.85 ± 0.005</td><td>10.47 ± 0.006</td></tr><tr><td>Density (g/mL)</td><td>1.011 ± 0.002</td><td>1.004 ± 0.007</td><td>1.021 ± 0.002</td><td>1.017 ± 0.003</td></tr><tr><td>Total Dry Solids (g/L)</td><td>32.57 ± 0.13</td><td>45.67 ± 0.21</td><td>55.80 ± 0.21</td><td>51.74 ± 0.93</td></tr><tr><td>Ash (g/L)</td><td>15.99 ± 0.42</td><td>16.77 ± 1.22</td><td>23.69 ± 0.33</td><td>20.84 ±1.60</td></tr><tr><td>Lignin (g/L)</td><td>11.6</td><td>12.6</td><td>24.3</td><td>19.0</td></tr><tr><td>Total monosaccharides (g/L)</td><td>3.812</td><td>4.004</td><td>4.239</td><td>5.049</td></tr><tr><td>Glucose (g/L)</td><td>0.127</td><td>0.211</td><td>1.237</td><td>0.262</td></tr><tr><td>Xylose (g/L)</td><td>1.682</td><td>2.814</td><td>1.781</td><td>2.624</td></tr><tr><td>Arabinose (g/L)</td><td>0.706</td><td>0.240</td><td>0.428</td><td>0.649</td></tr><tr><td>Acetyl groups (g/L)</td><td>1.297</td><td>0.739</td><td>0.792</td><td>1.514</td></tr><tr><td>HMF <sup>2</sup> (g/L)</td><td>0.00</td><td>0.00</td><td>0.00</td><td>0.00</td></tr><tr><td>Furfural (g/L)</td><td>0.00</td><td>0.00</td><td>0.00</td><td>0.00</td></tr><tr><td>Electrical conductivity (mS/cm)</td><td>14.63 ± 0.01</td><td>13.007 ± 0.005</td><td>21.7 ± 0.42</td><td>21.4 ± 0.06</td></tr></table> |
e4c71ef41be5bcdc7a199ef116701b7498391b99f464274c77d3951fb9ffc8a2.png | simple | <table><tr><td>Serial number</td><td>Dose (mg/ml)</td><td>Size of NPs (nm)</td><td>Time (h)</td><td>Head</td><td>Tail</td><td>Comet</td><td>Head DNA</td><td>Tail DNA</td><td>Tail moment</td><td>Olive tail moment</td></tr><tr><td>1</td><td>0.0</td><td>Nil</td><td>0</td><td>51</td><td>52</td><td>103</td><td>72.62</td><td>27.37</td><td>14.23</td><td>10.27</td></tr><tr><td>2</td><td>1.0</td><td>100</td><td>12</td><td>50</td><td>51</td><td>104</td><td>72.62</td><td>26.43</td><td>14.12</td><td>10.17</td></tr><tr><td>3</td><td>1.0</td><td>100</td><td>24</td><td>51</td><td>52</td><td>103</td><td>72.61</td><td>27.32</td><td>14.13</td><td>10.17</td></tr><tr><td>4</td><td>1.0</td><td>100</td><td>36</td><td>52</td><td>53</td><td>104</td><td>72.51</td><td>27.03</td><td>14.23</td><td>10.23</td></tr><tr><td>5</td><td>1.0</td><td>100</td><td>48</td><td>51</td><td>52</td><td>104</td><td>72.61</td><td>27.31</td><td>14.34</td><td>11.23</td></tr><tr><td>6</td><td>1.0</td><td>50</td><td>12</td><td>50</td><td>51</td><td>104</td><td>72.62</td><td>26.43</td><td>14.12</td><td>10.17</td></tr><tr><td>7</td><td>1.0</td><td>50</td><td>24</td><td>51</td><td>52</td><td>102</td><td>71.12</td><td>27.32</td><td>14.13</td><td>10.17</td></tr><tr><td>8</td><td>1.0</td><td>50</td><td>36</td><td>52</td><td>53</td><td>104</td><td>72.51</td><td>27.03</td><td>14.23</td><td>10.23</td></tr><tr><td>9</td><td>1.0</td><td>50</td><td>48</td><td>51</td><td>52</td><td>104</td><td>72.61</td><td>27.31</td><td>14.34</td><td>11.23</td></tr><tr><td>10</td><td>3.0</td><td>100</td><td>12</td><td>77</td><td>56</td><td>133</td><td>82.5</td><td>17.49</td><td>9.79</td><td>7.79</td></tr><tr><td>11</td><td>3.0</td><td>100</td><td>24</td><td>111</td><td>144</td><td>255</td><td>85.39</td><td>18.62</td><td>21.03</td><td>12.82</td></tr><tr><td>12</td><td>3.0</td><td>100</td><td>36</td><td>105</td><td>176</td><td>281</td><td>73.24</td><td>26.75</td><td>57.04</td><td>25.17</td></tr><tr><td>13</td><td>3.0</td><td>100</td><td>48</td><td>109</td><td>116</td><td>225</td><td>60.67</td><td>39.32</td><td>45.6</td><td>33.83</td></tr><tr><td>14</td><td>3.0</td><td>50</td><td>12</td><td>83</td><td>42</td><td>125</td><td>89.12</td><td>10.87</td><td>4.56</td><td>4.66</td></tr><tr><td>15</td><td>3.0</td><td>50</td><td>24</td><td>71</td><td>62</td><td>133</td><td>81.98</td><td>18.01</td><td>11.17</td><td>8.18</td></tr><tr><td>16</td><td>3.0</td><td>50</td><td>36</td><td>71</td><td>74</td><td>245</td><td>91.25</td><td>18.74</td><td>6.47</td><td>8.23</td></tr><tr><td>17</td><td>3.0</td><td>50</td><td>48</td><td>75</td><td>121</td><td>296</td><td>57.59</td><td>42.41</td><td>51.3</td><td>27.63</td></tr><tr><td>18</td><td>5.0</td><td>100</td><td>12</td><td>83</td><td>32</td><td>115</td><td>90.96</td><td>9.03</td><td>2.89</td><td>4.22</td></tr><tr><td>19</td><td>5.0</td><td>100</td><td>24</td><td>77</td><td>52</td><td>129</td><td>70.83</td><td>15.16</td><td>15.16</td><td>12.64</td></tr><tr><td>20</td><td>5.0</td><td>100</td><td>36</td><td>129</td><td>74</td><td>203</td><td>83.72</td><td>16.27</td><td>12.04</td><td>14.34</td></tr><tr><td>21</td><td>5.0</td><td>100</td><td>48</td><td>105</td><td>176</td><td>281</td><td>73.24</td><td>26.75</td><td>47.09</td><td>25.17</td></tr><tr><td>22</td><td>5.0</td><td>50</td><td>12</td><td>113</td><td>87</td><td>200</td><td>85.8</td><td>14.19</td><td>12.34</td><td>10.42</td></tr><tr><td>23</td><td>5.0</td><td>50</td><td>24</td><td>115</td><td>132</td><td>247</td><td>80.92</td><td>19.07</td><td>25.18</td><td>16.43</td></tr><tr><td>24</td><td>5.0</td><td>50</td><td>36</td><td>85</td><td>155</td><td>240</td><td>65.69</td><td>34.32</td><td>53.17</td><td>27.82</td></tr><tr><td>25</td><td>5.0</td><td>50</td><td>48</td><td>65</td><td>135</td><td>242</td><td>35.69</td><td>64.31</td><td>86.8</td><td>41.53</td></tr></table> |
a66430e2942fd55505a353922a8e734286c72e2812e84220b5b24ee6ed380206.png | simple | <table><tr><td></td><td>VAI</td><td>WC</td><td>WHtR</td><td>P-value (compare WC and VAI)</td><td>P-value (compare WHtR and VAI)</td></tr><tr><td>Composite outcomes</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>T = 4 years</td><td>60.85 ± 2.87</td><td>59.26 ± 3.09</td><td>59.98 ± 3.07</td><td>0.63</td><td>0.79</td></tr><tr><td>T = 5 years</td><td>59.67 ± 2.97</td><td>60.69 ± 3.09</td><td>60.79 ± 3.08</td><td>0.76</td><td>0.73</td></tr><tr><td>T = 6 years</td><td>62.82 ± 3.01</td><td>61.83 ± 3.17</td><td>62.42 ± 3.14</td><td>0.77</td><td>0.90</td></tr><tr><td>CV outcomes</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>T = 4 years</td><td>63.12 ± 3.06</td><td>62.23 ± 3.38</td><td>63.26 ± 3.36</td><td>0.80</td><td>0.97</td></tr><tr><td>T = 5 years</td><td>61.76 ± 3.16</td><td>63.06 ± 3.28</td><td>62.97 ± 3.29</td><td>0.71</td><td>0.73</td></tr><tr><td>T = 6 years</td><td>65.56 ± 3.15</td><td>64.31 ± 3.33</td><td>64.65 ± 3.31</td><td>0.72</td><td>0.79</td></tr><tr><td>All-cause mortality</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>T = 4 years</td><td>57.41 ± 3.51</td><td>51.87 ± 3.91</td><td>51.44 ± 3.78</td><td>0.22</td><td>0.15</td></tr><tr><td>T = 5 years</td><td>57.41 ± 3.51</td><td>54.74 ± 3.62</td><td>54.91 ± 3.56</td><td>0.74</td><td>0.76</td></tr><tr><td>T = 6 years</td><td>57.08 ± 3.28</td><td>57.56 ± 3.54</td><td>58.16 ± 3.49</td><td>0.90</td><td>0.76</td></tr></table> |
006dd7b1bbfe895b7395ab5f3f5de440380162aca0185de3f4bed5daa4ae8d3b.png | simple | <table><tr><td> </td><td>≤44 yrs</td><td>45 – 59 yrs</td><td>60 – 74 yrs</td><td>≥75 yrs</td></tr><tr><td>Indication</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Ischemia/CAD</td><td>12.1%</td><td>37.7%</td><td>48.1%</td><td>49.5%</td></tr><tr><td>Myocarditis/CMP</td><td>63.6%</td><td>36.6%</td><td>22.5%</td><td>16.5%</td></tr><tr><td>Viability</td><td>5.3%</td><td>17.0%</td><td>19.2%</td><td>22.4%</td></tr><tr><td>Stress CMR</td><td>13.7%</td><td>38.0%</td><td>47.5%</td><td>47.9%</td></tr><tr><td>Image quality</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Good</td><td>92.6%</td><td>90.8%</td><td>86.2%</td><td>80.1%</td></tr><tr><td>Moderate</td><td>6.3%</td><td>8.0%</td><td>11.9%</td><td>16.9%</td></tr><tr><td>Poor</td><td>1.1%</td><td>1.2%</td><td>1.9%</td><td>3.0%</td></tr><tr><td>Complications</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>None</td><td>98.4%</td><td>96.7%</td><td>95.5%</td><td>94.4%</td></tr><tr><td>Mild</td><td>1.6%</td><td>3.3%</td><td>4.5%</td><td>5.5%</td></tr><tr><td>Severe</td><td>0.0%</td><td>0.1%</td><td>0.0%</td><td>0.0%</td></tr><tr><td>New diagnosis</td><td>9.3%</td><td>9.5%</td><td>8.7%</td><td>7.7%</td></tr><tr><td>Therapeutic consequence</td><td>40.4%</td><td>51.9%</td><td>58.4%</td><td>64.6%</td></tr></table> |
41833138f18448ae3f68d39982db492fe64564353de71e667983f5545c586281.png | simple | <table><tr><td></td><td>TC (mmol/L)</td><td>TG (mmol/L)</td><td>HDL (mmol/L)</td><td>LDL (mmol/L)</td></tr><tr><td>control</td><td>13.8 ± 0.3</td><td>1.4 ± 0.2</td><td>3.7 ± 0.9</td><td>8.2 ± 0.8</td></tr><tr><td>agmatine</td><td>19 ± 4.1(<i>p</i> = 0.052)</td><td>1.7 ± 0.6 (NS)</td><td>8.6 ± 1.8 *</td><td>11.7 ± 2.4 (NS)</td></tr></table> |
7e2647202ebcec61d22444bd28abf58f639db57621b9217dda466bb55ebc8c86.png | complex | <table><tr><td>Exposure variables<sup>a</sup>\Percentile<sup>b</sup></td><td>Min</td><td>5th</td><td>25th</td><td>50th</td><td>75th</td><td>95th</td><td>Max</td></tr><tr><td colspan="8">As metabolites (μg g<sup>−1</sup> crea)</td></tr><tr><td>MMA</td><td>0.06</td><td>0.08</td><td>0.19</td><td>0.40 (1.10)<sup>c</sup></td><td>1.67</td><td>6.14</td><td>28.5</td></tr><tr><td>DMA</td><td>0.07</td><td>3.09</td><td>11.27</td><td>20.73 (14.58)</td><td>29.5</td><td>70.75</td><td>129.1</td></tr><tr><td>iAs</td><td>0.11</td><td>0.19</td><td>0.41</td><td>0.83 (0.61)</td><td>1.33</td><td>4.74</td><td>6.55</td></tr><tr><td>tAs</td><td>0.34</td><td>3.76</td><td>12.09</td><td>23.19 (16.29)</td><td>33.29</td><td>76.02</td><td>137.5</td></tr></table> |
f6ba78ad7c8c0c272d793c9e89db3cd45cec8d1152b7f9d738fcbe3da43ed55c.png | complex | <table><tr><td></td><td colspan="5">Self-rated health</td></tr><tr><td></td><td>Improved</td><td>Worsening</td><td>Sustained good</td><td>Sustained poor</td><td>Total</td></tr><tr><td></td><td>277 (6)</td><td>556 (13)</td><td>2864 (68)</td><td>543 (13)</td><td>4240 (100)</td></tr><tr><td>Sex</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> Female</td><td>241 (7)</td><td>474 (13)</td><td>2370 (67)</td><td>475 (13)</td><td>3560 (100)</td></tr><tr><td> Male</td><td>36 (5)</td><td>82 (12)</td><td>494 (73)</td><td>68 (10)</td><td>680 (100)</td></tr><tr><td>Age (mean ± SD)<sup>a</sup></td><td>46 ± 9</td><td>48 ± 9</td><td>46 ± 9</td><td>49 ± 8</td><td>46 ± 9</td></tr><tr><td>Current smoker (<i>n</i>, %)</td><td>78 (7)</td><td>184 (17)<sup>b</sup></td><td>657 (59)<sup>b</sup></td><td>191 (17)<sup>b</sup></td><td>1110 (100)</td></tr><tr><td>Body mass index (BMI)</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> Underweight (>18.5)</td><td>4 (10)</td><td>4 (10)</td><td>28 (70)</td><td>4 (10)</td><td>40 (100)</td></tr><tr><td> Normal weight (18.5–24.9)</td><td>126 (5)</td><td>264 (11)</td><td>1706 (74)</td><td>232 (10)</td><td>2328 (100)</td></tr><tr><td> Overweight (25.0–29.9)</td><td>106 (8)</td><td>201 (14)</td><td>873 (63)</td><td>206 (15)</td><td>1386 (100)</td></tr><tr><td> Obesity (<29.9)</td><td>39 (9)</td><td>76 (19)</td><td>202 (50)</td><td>89 (22)</td><td>406 (100)</td></tr><tr><td colspan="6">Financial situation at baseline</td></tr><tr><td> Good</td><td>80 (4)</td><td>195 (11)</td><td>1398 (78)</td><td>131 (7)</td><td>1804 (100)</td></tr><tr><td> Neither/nor</td><td>143 (8)</td><td>250 (14)</td><td>1128 (63)</td><td>275 (15)</td><td>1789 (100)</td></tr><tr><td> Strained</td><td>61 (9)</td><td>111 (17)</td><td>338 (52)</td><td>137 (21)</td><td>647 (100)</td></tr><tr><td colspan="6">Change in financial situation</td></tr><tr><td> Improved</td><td>61 (7)</td><td>102 (12)</td><td>582 (70)</td><td>91 (11)</td><td>835 (100)</td></tr><tr><td> Unchanged</td><td>179 (6)</td><td>371 (13)</td><td>2025 (69)</td><td>362 (12)</td><td>2937 (100)</td></tr><tr><td> Worsening</td><td>37 (8)</td><td>83 (18)</td><td>257 (55)</td><td>90 (19)</td><td>468 (100)</td></tr><tr><td colspan="6">Education at baseline</td></tr><tr><td> Further</td><td>162 (7)</td><td>282 (12)</td><td>1697 (70)</td><td>268 (11)</td><td>2401 (100)</td></tr><tr><td> Non-academic</td><td>115 (6)</td><td>274 (15)</td><td>1167 (63)</td><td>275 (15)</td><td>1839 (100)</td></tr><tr><td colspan="6">Managerial responsibility at baseline</td></tr><tr><td> Top manager</td><td>57 (6)</td><td>109 (11)</td><td>673 (71)</td><td>109 (11)</td><td>948 (100)</td></tr><tr><td> Other<sup>c</sup></td><td>220 (7)</td><td>447 (13)</td><td>2191 (67)</td><td>434 (13)</td><td>3292 (100)</td></tr></table> |
9fd85511db4b9224e313b8df0d205e7cb487b2c329edbbf4a2a0fcb0bede1291.png | simple | <table><tr><td>microRNA</td><td>Inhibitor Agent</td><td>Type of Disease</td><td>Investigation Status</td><td>Company/Ref</td></tr><tr><td>miR-10b</td><td>ASO</td><td>Glioblastoma</td><td>Preclinical</td><td>Regulus Therapeutics [108]</td></tr><tr><td>miR-21</td><td>ASO</td><td>HCC, fibrosis</td><td>Preclinical</td><td>Regulus Therapeutics [109,110]</td></tr><tr><td>miR-155</td><td>LNA-modified</td><td>T cell lymphoma and mycosis fungoides</td><td>Phase I</td><td>miRagen Therapeutics [111]</td></tr><tr><td>miR-221</td><td>ASO</td><td>Pancreatic carcinoma</td><td>Preclinical</td><td>Regulus Therapeutics [110]</td></tr><tr><td>miR-122</td><td>LNA-modified</td><td>HCV</td><td>Phase II</td><td>Santaris Pharma [112,113]</td></tr></table> |
c0eb25060b8662f3d3a916e78347f70e34495129aaf159aa158f3ae4cd17a7d6.png | complex | <table><tr><td rowspan="2">Clinical variables</td><td colspan="2">PFS</td><td colspan="2">OS</td></tr><tr><td>HR (95%CI)</td><td><i>P</i> value</td><td>HR (95%CI)</td><td><i>P</i> value</td></tr><tr><td>Univariate analysis</td><td></td><td></td><td></td><td></td></tr><tr><td>Age</td><td>0.999 (0.975-1.023)</td><td>0.915</td><td>1.003 (0.977-1.030)</td><td>0.814</td></tr><tr><td>Histologyclear cellEndometrioidMixed</td><td>Reference0.967 (0.585-1.671)1.896 (0.903-3.982)</td><td>0.286</td><td>Reference0.910 (0.514-1.611)1.845 (0.867-3.926)</td><td>0.282</td></tr><tr><td>ECOG performance0-12-3</td><td>Reference1.895 (0.913-3.932)</td><td>0.088</td><td>Reference1.567 (0.678-3.621)</td><td>0.296</td></tr><tr><td>FIGO stageEarly stage (I-II)Late stage (III-IV)</td><td>Reference10.367 (6.460-16.638)</td><td><0.001</td><td>Reference7.413 (4.526-12.139)</td><td><0.001</td></tr><tr><td>Lymph node metastasisnegativepositive</td><td>Reference4.707 (2.786-7.952)</td><td><0.001</td><td>Reference3.048 (1.684-5.517)</td><td><0.001</td></tr><tr><td>Intraperitoneal metastasisnegativepositive</td><td>Reference6.182 (3.908-9.778)</td><td><0.001</td><td>Reference5.194 (3.213-8.398)</td><td><0.001</td></tr><tr><td>Residual tumor (cm)≤ 1> 1</td><td>Reference5.639 (3.375-9.423)</td><td><0.001</td><td>Reference4.556 (2.651-7.831)</td><td><0.001</td></tr><tr><td>Preoperative ascites (ml)< 500≥ 500</td><td>Reference2.914 (1.682-5.047)</td><td><0.001</td><td>Reference2.653 (1.473-4.779)</td><td>0.001</td></tr><tr><td>Preoperative CA125 (U/ml)< 35≥ 35</td><td>Reference2.524 (1.561-4.079)</td><td><0.001</td><td>Reference2.570 (1.536-4.301)</td><td><0.001</td></tr><tr><td>Endometriosisnegativepositive</td><td>Reference0.187 (0.086-0.405)</td><td><0.001</td><td>Reference0.238 (0.109-0.518)</td><td><0.001</td></tr><tr><td>Multivariate analysis</td><td></td><td></td><td></td><td></td></tr><tr><td>FIGO stageEarly stage (I-II)Late stage (III-IV)</td><td>Reference8.642 (5.339-13.988)</td><td><0.001</td><td>Reference6.158(3.732-10.163)</td><td><0.001</td></tr><tr><td>Preoperative CA125 (U/ml)< 35≥ 35</td><td>Reference2.033 (1.249-3.309)</td><td>0.003</td><td>Reference2.150 (1.275-3.626)</td><td>0.010</td></tr><tr><td>Endometriosisnegativepositive</td><td>Reference0.284 (0.130-0.623)</td><td>0.002</td><td>Reference0.349 (0.159-0.765)</td><td>0.009</td></tr></table> |
005bc06d6056f0d26fba21be7d8d62379886acead49327c1ae44ed1ba2fa7762.png | simple | <table><tr><td>Evidence code type</td><td>Evidence code</td><td>Annotation errors</td><td>Total annotations</td><td>Percentage error rate</td></tr><tr><td>Experimental(manually assigned)</td><td>EXP</td><td>977</td><td>5360</td><td>18.23</td></tr><tr><td></td><td>IDA</td><td>12</td><td>105764</td><td>0.01</td></tr><tr><td></td><td>IMP</td><td>84</td><td>88283</td><td>0.10</td></tr><tr><td></td><td>IEP</td><td>0</td><td>10129</td><td>0.00</td></tr><tr><td></td><td>IPI</td><td>0</td><td>29877</td><td>0.00</td></tr><tr><td></td><td>IGI</td><td>0</td><td>12914</td><td>0.00</td></tr><tr><td>Computational Analysis(manually assigned)</td><td>ISS</td><td>85</td><td>228605</td><td>0.04</td></tr><tr><td></td><td>ISO</td><td>1</td><td>2975</td><td>0.03</td></tr><tr><td></td><td>ISA</td><td>0</td><td>5921</td><td>0.00</td></tr><tr><td></td><td>ISM</td><td>0</td><td>143</td><td>0.00</td></tr><tr><td></td><td>IGC</td><td>0</td><td>483</td><td>0.00</td></tr><tr><td></td><td>RCA</td><td>3</td><td>75175</td><td>0.00</td></tr><tr><td>Author statement(manually assigned)</td><td>TAS</td><td>4070</td><td>46888</td><td>8.68</td></tr><tr><td></td><td>NAS</td><td>3</td><td>23578</td><td>0.01</td></tr><tr><td>Curator statement(manually assigned)</td><td>IC</td><td>0</td><td>5682</td><td>0.00</td></tr><tr><td></td><td>ND</td><td>0</td><td>171817</td><td>0.00</td></tr><tr><td>Automatically Assigned</td><td>IEA</td><td>639</td><td>844441</td><td>0.08</td></tr></table> |
2d7ec28cd4a544c5c752fae124644d45267581f3fe146a7086a09cf2424cd84a.png | simple | <table><tr><td>Image</td><td>Speed up</td></tr><tr><td>Spine (MRI)</td><td>32.7%</td></tr><tr><td>Chest (X-ray)</td><td>33.1%</td></tr><tr><td>Fetus (ultrasonic)</td><td>52.7%</td></tr><tr><td>Head (CT)</td><td>53.6%</td></tr></table> |
665b155221e17eae750efe20c63c926c162f49791720c4f2654509f14bee91b9.png | simple | <table><tr><td>Primer target</td><td>Primer sequence (5′ to 3′)</td></tr><tr><td><i>Pgc-1α-a </i>F</td><td>GCTTGACTGGCGTCATTCG</td></tr><tr><td><i>Pgc-1α-a </i>R</td><td>ACAGAGTCTTGGCTGCACATGT</td></tr><tr><td><i>Pgc-1α-b </i>F</td><td>GACATGGATGTTGGGATTGTCA</td></tr><tr><td><i>Pgc-1α-b </i>R</td><td>ACCAACCAGAGCAGCACATTT</td></tr><tr><td><i>Pgc-1α-c</i> F</td><td>AGTGACATGGATGTTGGGATTG</td></tr><tr><td><i>Pgc-1α-c</i> R</td><td>GAATGCCTCCGGTTACTCACTT</td></tr><tr><td><i>Pgc-1α4</i> F</td><td>TCACACCAAACCCACAGAAA</td></tr><tr><td><i>Pgc-1α4</i> R</td><td>CTG GAA GAT ATG GCA CAT</td></tr><tr><td><i>FL-Pgc-1α</i>F</td><td>TGCCATTGTTAAGACCGA</td></tr><tr><td><i>FL-Pgc-1α</i>R</td><td>CCAGAGTCACCAAATGACC</td></tr><tr><td>total <i>NT-Pgc-1α</i> F</td><td>TGCCATTGTTAAGACCGA</td></tr><tr><td>total <i>NT-Pgc-1α</i> R</td><td>CCATATCTTCCAGTGACC</td></tr><tr><td>total <i>Pgc-1α</i> F</td><td>TGATGTGAATGACTTGGATACAGACA</td></tr><tr><td>total <i>Pgc-1α</i> R</td><td>GCT CAT TGT TGT ACT GGT TGG ATA TG</td></tr></table> |
937e85ddfe5bc19196b45fddb12efb5b8220088bcf60c528fb7bc71efecdbc44.png | complex | <table><tr><td rowspan="2">Variable</td><td colspan="2">Status of LLIN usage number (%)</td><td rowspan="2">Crude OR (95 % CI)</td><td rowspan="2">Adjusted OR (95 % CI)<sup>a</sup></td><td rowspan="2">p-value</td></tr><tr><td>Yes N = 11,574</td><td>No N = 2876</td></tr><tr><td colspan="6"><i>Age categories</i> (<i>years</i>)</td></tr><tr><td>0–5</td><td>2511 (83.12)</td><td>510 (16.88)</td><td>1</td><td>1</td><td></td></tr><tr><td>6–14</td><td>2808 (75.26)</td><td>923 (24.71)</td><td>1.17 (1.38–1.90)</td><td>1.29 (1.11–1.49)</td><td>0.001<sup>*</sup></td></tr><tr><td>15–45</td><td>4801 (80.86)</td><td>1136 (19.14)</td><td>1.17 (1.00–1.36)</td><td>1.02 (0.90–1.16)</td><td>0.745</td></tr><tr><td>>45</td><td>1450 (82.58)</td><td>306 (17.42)</td><td>1.04 (0.83–1.31)</td><td>0.69 (0.56–0.86)</td><td>0.001<sup>*</sup></td></tr><tr><td colspan="6"><i>Gender</i></td></tr><tr><td>Male</td><td>5542 (79.18)</td><td>1457 (20.82)</td><td></td><td></td><td></td></tr><tr><td>Female</td><td>6033 (80.96)</td><td>1418 (19.04)</td><td>0.90 (0.81–0.99)</td><td>0.94 (0.85–1.04)</td><td>0.236</td></tr><tr><td colspan="6"><i>Number of household members</i></td></tr><tr><td>1</td><td>354 (84.88)</td><td>62 (15.12)</td><td>1</td><td>1</td><td></td></tr><tr><td>2</td><td>683 (81.43)</td><td>156 (18.57)</td><td>1.28 (0.87–1.89)</td><td>1.48 (0.97–2.24)</td><td>0.066</td></tr><tr><td>3</td><td>1235 (85.05)</td><td>217 (14.95)</td><td>0.99 (0.65–1.51)</td><td>1.34 (0.83–2.18)</td><td>0.228</td></tr><tr><td>4</td><td>1924 (80.76)</td><td>459 (19.24)</td><td>1.34 (0.94–1.90)</td><td>1.97 (1.27–3.07)</td><td>0.003<sup>*</sup></td></tr><tr><td>5</td><td>1615 (79.53)</td><td>416 (20.41)</td><td>1.45 (1.01–2.06)</td><td>2.16 (1.38–3.38)</td><td>0.001<sup>*</sup></td></tr><tr><td>6</td><td>2231 (79.59)</td><td>572 (20.41)</td><td>1.44 (0.98–2.12)</td><td>2.25 (1.36–3.71)</td><td>0.002<sup>*</sup></td></tr><tr><td>>6</td><td>3532 (78.04)</td><td>994 (21.96)</td><td>1.58 (1.09–2.29)</td><td>2.27 (1.33–3.87)</td><td>0.003<sup>*</sup></td></tr><tr><td colspan="6"><i>Residence</i></td></tr><tr><td>Urban</td><td>2267 (80.98)</td><td>532 (19.02)</td><td></td><td></td><td></td></tr><tr><td>Rural</td><td>9306 (79.88)</td><td>2344 (20.12)</td><td>1.07 (0.81–1.42)</td><td>1.06 (0.79–1.41)</td><td>0.695</td></tr><tr><td colspan="6"><i>Number of sleeping rooms</i></td></tr><tr><td>1</td><td>3670 (82.21)</td><td>795 (17.79)</td><td>1</td><td>1</td><td></td></tr><tr><td>2</td><td>3871 (80.65)</td><td>929 (19.35)</td><td>1.11 (0.91–1.35)</td><td>0.90 (0.72–1.12)</td><td></td></tr><tr><td>3</td><td>2546 (78.45)</td><td>699 (21.55)</td><td>1.27 (1.02–1.57)</td><td>0.94 (0.73–1.21)</td><td>0.329</td></tr><tr><td>4</td><td>903 (77.68)</td><td>259 (22.32)</td><td>1.33 (0.99–1.79)</td><td>0.94 (0.67–1.32)</td><td>0.621</td></tr><tr><td>>4</td><td>421 (71.80)</td><td>165 (28.20)</td><td>1.81 (1.32–2.50)</td><td>1.25 (0.88–1.76)</td><td>0.732</td></tr><tr><td colspan="6"><i>Spraying of rooms with insecticide</i></td></tr><tr><td>No</td><td>10,909 (80.06)</td><td>2717 (19.94)</td><td></td><td></td><td></td></tr><tr><td>Yes</td><td>643 (80.29)</td><td>157 (19.71)</td><td>0.99 (0.65–1.49)</td><td>0.90 (0.88–1.76)</td><td>0.605</td></tr><tr><td colspan="6"><i>Number of children under 5</i> <i>years</i></td></tr><tr><td>0</td><td>3433 (76.80)</td><td>1037 (23.20)</td><td>1</td><td>1</td><td></td></tr><tr><td>1</td><td>3533 (81.37)</td><td>808 (18.63)</td><td>0.76 (0.63–0.92)</td><td>0.77 (0.61–0.98)</td><td>0.030<sup>*</sup></td></tr><tr><td>2</td><td>3268 (81.12)</td><td>761 (18.88)</td><td>0.77 (0.63–0.94)</td><td>0.77 (0.61–0.96)</td><td>0.023<sup>*</sup></td></tr><tr><td>>2</td><td>1340 (83.28)</td><td>269 (16.72)</td><td>0.66 (0.47–0.93)</td><td>0.67 (0.47–0.95)</td><td>0.027<sup>*</sup></td></tr><tr><td colspan="6"><i>Number of women of child bearing age</i></td></tr><tr><td>0</td><td>1784 (71.91)</td><td>697 (28.09)</td><td>1</td><td>1</td><td></td></tr><tr><td>1</td><td>7213 (83.03)</td><td>1474 (16.97)</td><td>0.52 (0.44–0.62)</td><td>0.46 (0.38–0.57)</td><td>0.001<sup>*</sup></td></tr><tr><td>>1</td><td>2576 (78.52)</td><td>705 (21.48)</td><td>0.70 (0.57–0.86)</td><td>0.49 (0.37–0.65)</td><td>0.001<sup>*</sup></td></tr><tr><td colspan="6"><i>Relationship structure</i></td></tr><tr><td>1 related adult</td><td>1784 (71.91)</td><td>331 (18.30)</td><td>1</td><td>1</td><td></td></tr><tr><td>2 related adults</td><td>7213 (83.03)</td><td>1108 (17.25)</td><td>0.93 (0.73–1.18)</td><td>1.29 (0.96–1.1.74)</td><td>0.004<sup>*</sup></td></tr><tr><td>3+ unrelated adults</td><td>2576 (78.52)</td><td>1437 (23.15)</td><td>1.34 (1.07–1.70)</td><td>1.60 (1.17–2.19)</td><td>0.870</td></tr><tr><td colspan="6"><i>Community distribution of malaria medicine</i></td></tr><tr><td>No</td><td>6270 (81.15)</td><td>1456 (18.85)</td><td>1</td><td>1</td><td></td></tr><tr><td>Yes</td><td>4840 (78.54)</td><td>1322 (21.46)</td><td>1.18 (0.99–1.39)</td><td>1.16 (0.97–1.38)</td><td>0.100</td></tr><tr><td>Do not know</td><td>452 (82.71)</td><td>95 (17.29)</td><td>0.90 (0.61–1.33)</td><td>0.87 (0.58–2.69)</td><td>0.504</td></tr></table> |
ca5b204d1e82faa4fad71ee0ce84e490256bd8ba6b9197d4f5837e050c3ad8ee.png | complex | <table><tr><td rowspan="2">Item</td><td colspan="4">Factor<sup>a</sup></td></tr><tr><td>I</td><td>II</td><td>III</td><td>IV</td></tr><tr><td>10. Surfing</td><td>.74</td><td>-.07</td><td>-.02</td><td>-.14</td></tr><tr><td>12. Flying Plane</td><td>.79</td><td>-.04</td><td>.09</td><td>-.12</td></tr><tr><td>13. Diving</td><td>.54</td><td>-.01</td><td>.01</td><td>.03</td></tr><tr><td>14. Skydiving</td><td>.66</td><td>.05</td><td>-.04</td><td>.30</td></tr><tr><td>16. Jumping from Heights</td><td>.81</td><td>.19</td><td>-.18</td><td>-.10</td></tr><tr><td>21. Skiing</td><td>.41</td><td>-.23</td><td>.15</td><td>.14</td></tr><tr><td>1. Wild Parties</td><td>-.09</td><td>.40</td><td>.14</td><td>.31</td></tr><tr><td>8. Disinhibited People</td><td>.05</td><td>.37</td><td>.39</td><td>-.08</td></tr><tr><td>17. Exciting People</td><td>.04</td><td>.69</td><td>-.17</td><td>-.01</td></tr><tr><td>19. Sexual Content Movies</td><td>.25</td><td>.36</td><td>.12</td><td>-.13</td></tr><tr><td>20. Alcohol</td><td>-.04</td><td>.84</td><td>.23</td><td>-.29</td></tr><tr><td>2. Body Smells</td><td>-.05</td><td>-.12</td><td>.42</td><td>.03</td></tr><tr><td>5. Marihuana</td><td>.04</td><td>-.11</td><td>.99</td><td>-.07</td></tr><tr><td>6. Hallucinogens Drugs</td><td>.01</td><td>.06</td><td>.90</td><td>-.08</td></tr><tr><td>9. Stimulants</td><td>-.08</td><td>.27</td><td>.60</td><td>.17</td></tr><tr><td>22. Dangerous Drugs</td><td>-.10</td><td>.34</td><td>.46</td><td>.14</td></tr><tr><td>3. Unpredictable Places</td><td>.11</td><td>-.04</td><td>.02</td><td>.48</td></tr><tr><td>7. Risk Appetite</td><td>.04</td><td>-.11</td><td>.13</td><td>.79</td></tr><tr><td>11. Unplanned Trip</td><td>.14</td><td>.01</td><td>.03</td><td>.41</td></tr><tr><td>15. Unpredictable Friends</td><td>.06</td><td>.21</td><td>-.09</td><td>.36</td></tr><tr><td>18. Boredom Rejection</td><td>-.24</td><td>.28</td><td>-.10</td><td>.48</td></tr><tr><td>23. Risk for Fun</td><td>.02</td><td>.27</td><td>.05</td><td>.44</td></tr><tr><td>Eigenvalues</td><td>6.58</td><td>2.89</td><td>1.58</td><td>1.31</td></tr><tr><td>% of Variance</td><td>29.91</td><td>13.13</td><td>7.19</td><td>5.96</td></tr><tr><td>Reliability estimate</td><td>.87</td><td>.82</td><td>.93</td><td>.77</td></tr></table> |
cfa3b384438e4c9b38984416790c725bb5eb03789da5399e83706e6be4fe08d2.png | complex | <table><tr><td>Components</td><td>Composite Alpha</td><td>Extracted variance</td><td>Interobserver Reliability<sup>a</sup></td><td>Item</td><td>Stand<sup>b</sup></td><td>Var. Error</td><td>Factor loading<sup>c</sup></td><td>Convergent validity<sup>d</sup></td><td>Discriminant validity</td></tr><tr><td rowspan="3">Component 1</td><td rowspan="3">0.79</td><td rowspan="3">0.56</td><td rowspan="3">84.9</td><td>Inflammation</td><td>0.59</td><td>0.65</td><td>0.59</td><td>4.64</td><td rowspan="5">0.50</td></tr><tr><td>Edema</td><td>0.74</td><td>0.45</td><td>0.74</td><td>6.11</td></tr><tr><td>Pain</td><td>0.89</td><td>0.21</td><td>0.81</td><td>6.68</td></tr><tr><td rowspan="2">Component 2</td><td rowspan="2">0.71</td><td rowspan="2">0.55</td><td rowspan="2">87.9</td><td>Abscess</td><td>0.71</td><td>0.49</td><td>0.78</td><td>5.24</td></tr><tr><td>Alveolar osteitis</td><td>0.78</td><td>0.39</td><td>0.78</td><td>5.74</td></tr></table> |
9629a756ed2ac80506e9e86a7fbe0b3f1e2dcf4da0b03f1083dd02e3aabf6d77.png | complex | <table><tr><td><i>LVH classification</i></td><td><i>LVH status</i></td><td><i>Total population QTd (ms)</i></td><td>p<i>-value</i></td><td><i>Normotensive group QTd (ms)</i></td><td>p<i>-value</i></td><td><i>Prehypertensive group QTd (ms)</i></td><td>p<i>-value</i></td></tr><tr><td rowspan="2">Sokolow–Lyon</td><td>No LVH</td><td>38.77 ± 11.31</td><td>0.88</td><td>39.11 ± 11.10</td><td>0.72</td><td>38.33 ± 11.72</td><td>0.88</td></tr><tr><td>LVH</td><td>38.13 ± 12.39</td><td></td><td>37.00 ± 11.94</td><td></td><td>39.25 ± 14.57</td><td></td></tr><tr><td rowspan="2">Araoye</td><td>No LVH</td><td>38.78 ± 10.78</td><td>0.88</td><td>39.36 ± 10.89</td><td>0.33</td><td>39.97 ± 10.67</td><td>0.54</td></tr><tr><td>LVH</td><td>38.20 ± 16.44</td><td></td><td>33.75 ± 13.77</td><td></td><td>41.17 ± 18.61</td><td></td></tr><tr><td rowspan="2">LVMI</td><td>No LVH</td><td>39.72 ± 10.24</td><td>0.97</td><td>40.60 ± 10.70</td><td>0.96</td><td>38.39 ± 9.58</td><td>0.87</td></tr><tr><td>LVH</td><td>40.00 ± 0.00</td><td></td><td>40.00 ± 0.00</td><td></td><td>40.00 ± 0.00</td><td></td></tr></table> |
1f0b1d75f5460db085495eaaf4eb6e5e78fdf8f9b23a4909fa72841cf2f7c946.png | complex | <table><tr><td></td><td colspan="2">Men</td><td colspan="2">Women</td></tr><tr><td></td><td>Overweight OR (95% CI)</td><td>Obese OR (95% CI)</td><td>Overweight OR (95% CI)</td><td>Obese OR (95% CI)</td></tr><tr><td>White</td><td>Ref</td><td>Ref</td><td>Ref</td><td>Ref</td></tr><tr><td>Black</td><td>2.20 (1.54, 3.15)</td><td>2.84 (1.54, 5.22)</td><td>2.03 (1.26, 3.26)</td><td>3.56 (1.57, 8.11)</td></tr><tr><td>Hispanic</td><td>1.89 (1.30, 2.75)</td><td>1.45 (0.69, 3.07)</td><td>1.34 (0.85, 2.13)</td><td>2.19 (0.96, 5.01)</td></tr><tr><td>Other</td><td>1.04 (0.48, 2.23)</td><td>1.21 (0.23, 5.27)</td><td>1.58 (0.57, 4.35)</td><td>3.94 (0.94, 15.53)</td></tr></table> |
31e41ef606ebee6a642c8f3a76357e8833b2a8f5c46a423dcbf1a341141c65c5.png | complex | <table><tr><td></td><td colspan="9">Study period (weeks)</td></tr><tr><td>Time point</td><td>3/16</td><td>4/16</td><td>5/16</td><td>6/16</td><td>7/16</td><td>8/16</td><td>9/16</td><td>10/16</td><td>11/16</td></tr><tr><td colspan="10">Enrolment</td></tr><tr><td> Recruitment</td><td>X</td><td>X</td><td>X</td><td>X</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> Eligibility screen</td><td>X</td><td>X</td><td>X</td><td>X</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> Informed consent</td><td>X</td><td>X</td><td>X</td><td>X</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> Allocation</td><td>X</td><td>X</td><td>X</td><td>X</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td colspan="10">Interventions:</td></tr><tr><td> Discussion group</td><td>X</td><td>X</td><td>X</td><td>X</td><td>X</td><td>X</td><td></td><td></td><td></td></tr><tr><td> Minimal support group (MSG)</td><td>X</td><td>X</td><td>X</td><td>X</td><td>X</td><td>X</td><td></td><td></td><td></td></tr><tr><td> Wait list control group (access to MSG)</td><td></td><td></td><td></td><td></td><td>X</td><td>X</td><td>X</td><td>X</td><td>X</td></tr><tr><td colspan="10">Assessments</td></tr><tr><td> T1</td><td>X</td><td>X</td><td>X</td><td>X</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> Credibility/expectancy</td><td>X</td><td>X</td><td>X</td><td>X</td><td>X</td><td></td><td></td><td></td><td></td></tr><tr><td> T2</td><td></td><td></td><td>X</td><td>X</td><td>X</td><td></td><td></td><td></td><td></td></tr><tr><td> T3</td><td></td><td></td><td></td><td></td><td>X</td><td>X</td><td>X</td><td></td><td></td></tr><tr><td> Study completion</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td>X</td></tr></table> |
7e7a8fc012348ae8ebb61ae0f1da056197e35c03cebf95612e172320607f0452.png | complex | <table><tr><td rowspan="2">Current year</td><td colspan="4">Next year</td></tr><tr><td>Breeders, %</td><td><i>N</i></td><td>Failed breeders, %</td><td><i>N</i></td></tr><tr><td>Breeders</td><td>78.9</td><td>172</td><td>21.1</td><td>46</td></tr><tr><td>Failed breeders</td><td>82.0</td><td>50</td><td>18.0</td><td>11</td></tr></table> |
6db7c5b60d79444e261b4ba60c9170dbe30f2a51712edec65d2d91d3b5ab00bd.png | complex | <table><tr><td></td><td></td><td colspan="3">Medical claims with ICD-9-CM diagnosis codes</td></tr><tr><td>Characteristic</td><td>Total patients (<i>N </i>= 214)</td><td>Schizophrenia only (<i>n </i>= 44)</td><td>Bipolar disorder only (<i>n </i>= 162)</td><td>Schizophrenia and bipolar disorder (<i>n </i>= 8)</td></tr><tr><td colspan="5">Gender, <i>n</i> (%)</td></tr><tr><td> Male</td><td>74 (34.58)</td><td>24 (54.55)</td><td>48 (29.63)</td><td>2 (25.00)</td></tr><tr><td> Female</td><td>140 (65.42)</td><td>20 (45.45)</td><td>114 (70.37)</td><td>6 (75.00)</td></tr><tr><td>Age, mean (±SD, median)</td><td>43.02 (±12.84, 45)</td><td>46.30 (±10.98, 46.50)</td><td>41.99 (±13.34, 45)</td><td>46.00 (±8.67, 44)</td></tr><tr><td colspan="5">Mental health conditions, <i>n</i> (%)</td></tr><tr><td> Depression</td><td>76 (35.51)</td><td>5 (11.36)</td><td>69 (42.59)</td><td>2 (25.00)</td></tr><tr><td> Anxiety disorder</td><td>49 (22.90)</td><td>3 (6.82)</td><td>45 (27.78)</td><td>1 (12.50)</td></tr><tr><td> Insomnia</td><td>21 (9.81)</td><td>2 (4.55)</td><td>18 (11.11)</td><td>1 (12.50)</td></tr><tr><td> Substance abuse</td><td> </td><td> </td><td> </td><td>0</td></tr><tr><td>Alcohol</td><td>8 (3.74)</td><td>1 (2.27)</td><td>7 (4.32)</td><td>0</td></tr><tr><td>Opiates</td><td>4 (1.87)</td><td>0</td><td>4 (2.47)</td><td>0</td></tr></table> |
1a71f4d402958090e7ae3a071581b7f2aba7e065a9b612e47258faf328603027.png | simple | <table><tr><td></td><td>Mean</td><td><i>SD</i></td><td>Range</td><td>Skewa</td><td>Kurtosisa</td></tr><tr><td>Adolescent self‐worth</td><td>26.85</td><td>4.53</td><td>16–46</td><td>−0.47 (−0.46)</td><td>3.31 (3.30)</td></tr><tr><td>Parent report parent–child closeness</td><td>39.09</td><td>4.66</td><td>21–50</td><td>−0.09 (−0.08)</td><td>2.75 (2.76)</td></tr><tr><td>Parent report expressions of affection</td><td>57.35</td><td>14.55</td><td>23–123</td><td>0.41 (0.45)</td><td>3.08 (3.34)</td></tr></table> |
dbaa204675920ea44999cd73b666703986ed0174a36e789e3d231c453a62e3f2.png | complex | <table><tr><td>Subthemes</td><td>Data extracts</td></tr><tr><td rowspan="5">4.1 Lack of empathy with the challenges of medication usage</td><td>‘ ... They don't <i>understand</i> that you are wearing stuff on your head that makes you smell like you're painting fences ... it's really <i>frustrating</i>, they [clinicians] need to look at the impact of these treatments, maybe then they could understand why people aren't sticking to them.’ [P11: using topical therapy]</td></tr><tr><td>‘My [GP] said, “Well use the coal tar during the day,” and I said, “Well I can't because it's too messy ... ,” and all she said was “Oh, well just wear gloves.” But it's <i>impossible</i> as I'm working with papers all the time.’ [P9: prescribed topical therapy but using herbal therapies]</td></tr><tr><td>‘It did kind of put me under a bit of stress, it affected my condition hugely. I really don't understand why [I was unable to be prescribed my preferred biologic], I mean, I try not to think about it too much but at the time it did cause me a lot of <i>worry and upset</i> ... there might have been a very good reason behind it but they didn't want to share it with me.’ [P3: prescribed a biologic]</td></tr><tr><td>‘I had to really look [possible side‐effects] up myself on the Internet. She [clinician] was quite blasé about it ... and I was reading all these blogs about side‐effects which worried me, so I <i>wasn't happy</i> that I wasn't getting all the information.’ [P13: using topical and oral therapy]</td></tr><tr><td>‘Nobody has ever really asked me how I feel about my psoriasis or how I deal with my psoriasis. Or what my feelings are. Nobody has ever <i>asked</i> me that.’ [P15: using topical therapy and photochemotherapy]</td></tr><tr><td>4.2 Lack of support reinforced rejection of psoriasis therapies</td><td>‘I stopped going [to the GP] because they weren't <i>helping</i> ... because nothing [treatment] had worked there wasn't really much point in trying another one.’ [P9: prescribed topical therapy but using herbal therapies]</td></tr></table> |
5d2d41c6f4ae8791cdc6afe50225d536d8527474780ba05495f9aee58ad25a86.png | complex | <table><tr><td>Anatomical region</td><td>L/R</td><td>Cluster level P(corrected)</td><td>Size (voxels)</td><td>Voxel level P (FDR-corrected)</td><td>Voxel level P (uncorrected)</td><td colspan="3">MNI (mm) x y z</td><td>Voxel Z</td></tr><tr><td>Limbic lobe uncus</td><td>Left</td><td>0.015</td><td>92</td><td>0.232</td><td>0.000</td><td>−18</td><td>2</td><td>−22</td><td>4.13</td></tr><tr><td>Middle Frontal gyrus</td><td>Left</td><td>0.083</td><td>66</td><td>0.018</td><td>0.000</td><td>−18</td><td>46</td><td>−14</td><td>5.21</td></tr><tr><td>Cerebellum posterior Lobe</td><td>Right</td><td>0.025</td><td>89</td><td>0.125</td><td>0.000</td><td>26</td><td>−34</td><td>−40</td><td>3.98</td></tr></table> |
6402e7c730ce33cc5a23a4b67f08f337e70167bd47f3422b013a8bea8b5d73f3.png | complex | <table><tr><td>Landscape characteristics</td><td>Definition</td></tr><tr><td colspan="2">Habitat types</td></tr><tr><td> Floodplain</td><td>Open, seasonally flooded grasslands</td></tr><tr><td> Grassland</td><td>Open, shrubbed, savannah grasslands</td></tr><tr><td> <i>Acacia</i> woodland</td><td>Open woodland with >70% <i>Acacia</i> species</td></tr><tr><td> Riparian woodland</td><td>Tall open mixed woodland located in riverine or historic riverine areas</td></tr><tr><td> Mopane woodland</td><td><i>Colophosphermum mopane</i> dominated woodland</td></tr><tr><td colspan="2">Landscape metrics</td></tr><tr><td> Number of habitat patches (NP)</td><td>Measure of landscape fragmentation; metric equals the number of patches in the landscape. Value ranges from 1 if one patch covers entire landscape to a maximum equal to the total number of patches</td></tr><tr><td> Landscape mean patch shape index (MSI)</td><td>Measure of the average patch complexity within the landscape; metric equals 1 if average patch is square, increasing without limit as shape becomes more irregular</td></tr><tr><td> Index of juxtaposition and interspersion (IJI)</td><td>Measure of the intermixing of different habitat patches; probabilistic metric equals 0 if some habitat types are commonly found adjacent to each other but others are rarely found adjacent to each other, ranging to 100 when all habitat types are equally adjacent to all other habitat types</td></tr></table> |
23ad2de9f65280a727fc73cbfe0d1b550503a0f753c6a4d2b23ef7a9a0926b18.png | simple | <table><tr><td>Clinical features</td><td>Patients at onset n</td><td>Cumulative number of patients at eight years n</td></tr><tr><td>Dactylitis</td><td>15</td><td>24</td></tr><tr><td>Nail pitting</td><td>10</td><td>18</td></tr><tr><td>Psoriasis</td><td>11</td><td>14</td></tr><tr><td>Psoriasis-like rash</td><td>6</td><td>13</td></tr><tr><td>Enthesitis</td><td>37</td><td>41</td></tr></table> |
a669b21dfc592e48f2d11395f161f297d49b80605c7c6335219e3f3a169265a2.png | simple | <table><tr><td></td><td>Model definition(relevant year in brackets)</td><td>External data definition(data source in brackets)</td></tr><tr><td>Incidence</td><td>OUTCOME: Incidence of first AMI (2010)</td><td>Incidence of first AMI since 1998 (linked hospital episodes and mortality statistics, 2010).</td></tr><tr><td>Prevalence</td><td>Prevalence of ever having had an AMI (2010)</td><td>Prevalence of ever having had a doctor-diagnosed AMI (Health Survey for England, 2011).</td></tr><tr><td>Remission</td><td>Zero<sup>a</sup></td><td>Zero</td></tr><tr><td>Excess mortality</td><td>Excess mortality due to first AMI (2010)</td><td>Death where AMI is included anywhere on the death certificate (ONS mortality statistics, 2010).</td></tr></table> |
bd0da3a5954d55089f767a6fdf3ee47b8d0fc0a31edd2dc2a7acd7cdd4dfaac1.png | complex | <table><tr><td>Characteristics</td><td colspan="2">Potential patients (<i>n</i> = 10)</td><td colspan="2">Therapists (stage 1) (<i>n</i> = 4)</td><td colspan="2">Therapists (stage 3) (<i>n</i> = 5)</td></tr><tr><td></td><td><i>n</i></td><td>%</td><td><i>n</i></td><td>%</td><td><i>n</i></td><td>%</td></tr><tr><td colspan="7">Sex</td></tr><tr><td> Male</td><td>2</td><td>20</td><td>2</td><td>50</td><td>2</td><td>40</td></tr><tr><td> Female</td><td>8</td><td>80</td><td>2</td><td>50</td><td>3</td><td>60</td></tr><tr><td colspan="7">Age (in years)</td></tr><tr><td> 18–30</td><td>2</td><td>20</td><td>0</td><td>0</td><td>0</td><td>0</td></tr><tr><td> 30–50</td><td>4</td><td>40</td><td>2</td><td>50</td><td>3</td><td>60</td></tr><tr><td> 50–70</td><td>4</td><td>40</td><td>2</td><td>50</td><td>2</td><td>40</td></tr><tr><td colspan="7">Nationality</td></tr><tr><td> British</td><td>10</td><td>100</td><td>4</td><td>100</td><td>5</td><td>100</td></tr><tr><td colspan="7">Highest level of education</td></tr><tr><td> < A-levels</td><td>1</td><td>10</td><td>0</td><td>0</td><td>0</td><td>0</td></tr><tr><td> A-levels</td><td>2</td><td>20</td><td>0</td><td>0</td><td>0</td><td>0</td></tr><tr><td> University degree</td><td>5</td><td>50</td><td>1</td><td>25</td><td>1</td><td>20</td></tr><tr><td> Post-graduate diploma</td><td>0</td><td></td><td>1</td><td>25</td><td>2</td><td>40</td></tr><tr><td> Post-graduate degree</td><td>1</td><td>10</td><td>1</td><td>25</td><td>1</td><td>20</td></tr><tr><td> Doctoral degree</td><td>1</td><td>10</td><td>1</td><td>25</td><td>1</td><td>20</td></tr><tr><td colspan="7">Mental health problem</td></tr><tr><td> Depression</td><td>10</td><td>100</td><td colspan="2">N/A</td><td colspan="2">N/A</td></tr><tr><td> Anxiety</td><td>8</td><td>80</td><td colspan="2">N/A</td><td colspan="2">N/A</td></tr><tr><td colspan="7">Previous therapy experience</td></tr><tr><td> None</td><td>4</td><td>40</td><td colspan="2">N/A</td><td colspan="2">N/A</td></tr><tr><td> Cognitive behavioural therapy</td><td>4</td><td>40</td><td colspan="2">N/A</td><td colspan="2">N/A</td></tr><tr><td> Mindfulness-based cognitive therapy</td><td>3</td><td>30</td><td colspan="2">N/A</td><td colspan="2">N/A</td></tr><tr><td> Behavioural activation</td><td>1</td><td>10</td><td colspan="2">N/A</td><td colspan="2">N/A</td></tr><tr><td> Interpersonal psychotherapy</td><td>1</td><td>10</td><td colspan="2">N/A</td><td colspan="2">N/A</td></tr><tr><td colspan="7">Area(s) of clinical training</td></tr><tr><td> Cognitive behavioural therapy</td><td>N/A</td><td></td><td>4</td><td>100</td><td>5</td><td>100</td></tr><tr><td> Behavioural activation</td><td>N/A</td><td></td><td>4</td><td>100</td><td>4</td><td>80</td></tr><tr><td> Eye movement desensitisation and reprocessing</td><td>N/A</td><td></td><td>1</td><td>25</td><td>2</td><td>40</td></tr><tr><td> Interpersonal psychotherapy</td><td>N/A</td><td></td><td>1</td><td>25</td><td>1</td><td>20</td></tr><tr><td> Dialectical behaviour therapy</td><td>N/A</td><td></td><td>1</td><td>25</td><td>1</td><td>20</td></tr></table> |
927313040d9521fb3ab3614c2e9c18d5ef6cddc1fcc136e98c2dc8756654ef67.png | complex | <table><tr><td>Gene </td><td> Organ</td><td> LPS</td><td> LPS + HOCbl</td><td><i>P</i> value (versus LPS)</td></tr><tr><td rowspan="2"> IL-1<i>β</i></td><td> Liver</td><td> − 8.30 ± 0.30</td><td> −10.6 ± 0.3*</td><td> 0.0056</td></tr><tr><td> Lung</td><td>2.70 ± 0.50</td><td> 2.1 ± 0.1</td><td> 0.3046</td></tr><tr><td rowspan="2"> TNF-<i>α</i></td><td> Liver</td><td> − 86.90 ± 0.10</td><td> −68.6 ± 0.2*</td><td> <0.0001</td></tr><tr><td> Lung</td><td> − 2.10 ± 0.20</td><td> −11.4 ± 0.1*</td><td> <0.0001</td></tr></table> |
3e531c72c19a9681b8c36bdeb3672637439a6e2b292daaac40993bb5e631f061.png | complex | <table><tr><td> </td><td colspan="2">Limbs = 421</td></tr><tr><td> </td><td>Mercury</td><td>Electronic device</td></tr><tr><td>Brachial SBP (mmHg), mean (SD)</td><td>140 (17)</td><td>140 (17)</td></tr><tr><td>Dorsalis pedis SBP (mmHg), mean (SD)</td><td>158 (30)</td><td>157 (30)</td></tr><tr><td>Posterior tibial SBP (mmHg), mean (SD)</td><td>160 (31)</td><td>160 (30)</td></tr><tr><td>ABI, n (%)</td><td> </td><td> </td></tr><tr><td>Normal (0.91–1.39)</td><td>340 (80.8)</td><td>344 (81.7)</td></tr><tr><td>Abnormal (≤ 0.90)</td><td>40 (9.5)</td><td>37 (8.8)</td></tr><tr><td>Calcification (≥ 1.40)</td><td>41 (9.7)</td><td>40 (9.5)</td></tr><tr><td>Abnormal (≤ 0.70)</td><td>14 (3.3)</td><td>12 (2.8)</td></tr></table> |
a98679457aaf7c2472e7093de601c4684221775c484f12abd55eb1106ad9da58.png | complex | <table><tr><td rowspan="2">Symptoms</td><td rowspan="2">Prop</td><td rowspan="2">95% CI</td><td rowspan="2">I<sup>2</sup> (%)</td><td>Pop</td><td colspan="2">Summary of case report data</td></tr><tr><td>Studies/Patients</td><td><i>n</i></td><td>%</td></tr><tr><td>Falls</td><td>0.48</td><td>0.20, 0.77</td><td>84</td><td>5/252</td><td>2</td><td>4</td></tr><tr><td>Fatigue</td><td>0.46</td><td>0.21, 0.72</td><td>92</td><td>8/333</td><td>18</td><td>38</td></tr><tr><td>Weakness</td><td>0.45</td><td>0.32, 0.58</td><td>49</td><td>14/247</td><td>13</td><td>27</td></tr><tr><td>Confusion</td><td>0.44</td><td>0.33, 0.56</td><td>85</td><td>22/710</td><td>16</td><td>33</td></tr><tr><td>Nausea</td><td>0.36</td><td>0.24, 0.48</td><td>76</td><td>14/405</td><td>10</td><td>21</td></tr><tr><td>Neurological symptoms</td><td>0.51</td><td>0.22, 0.80</td><td>76</td><td>8/37</td><td>10</td><td>21</td></tr><tr><td>Vomiting</td><td>0.35</td><td>0.25, 0.45</td><td>68</td><td>13/549</td><td>9</td><td>19</td></tr><tr><td>Dizziness</td><td>0.31</td><td>0.15, 0.51</td><td>92</td><td>8/488</td><td>5</td><td>10</td></tr><tr><td>Unconsciousness</td><td>0.30</td><td>0.15, 0.48</td><td>75</td><td>11/181</td><td>13</td><td>27</td></tr><tr><td>Seizures</td><td>0.19</td><td>0.08, 0.33</td><td>84</td><td>10/405</td><td>10</td><td>21</td></tr></table> |
cbc0ca5de4e1baf5da4de4c802434d401a7349342e77971bf6411a9755ce44a7.png | complex | <table><tr><td rowspan="3">Chemicals</td><td colspan="4">24 h Area under the curve (mg/L-h)</td></tr><tr><td colspan="4">Metabolic scenario<sup>a</sup></td></tr><tr><td><i>E</i><sub>min⁡</sub></td><td><i>E</i><sub>max⁡</sub></td><td>LMCI</td><td>UMCI</td></tr><tr><td>Benzene</td><td>0.437</td><td>0.125</td><td>0.155</td><td>0.138</td></tr><tr><td>Bromochloromethane</td><td>0.913</td><td>0.229</td><td>0.305</td><td>0.257</td></tr><tr><td>Bromodichloromethane</td><td>2.380</td><td>0.356</td><td>0.523</td><td>0.422</td></tr><tr><td>Carbon tetrachloride</td><td>0.34</td><td>0.153</td><td>0.224</td><td>0.186</td></tr><tr><td>Chloroethane</td><td>0.156</td><td>0.069</td><td>0.084</td><td>0.076</td></tr><tr><td>Chloroform</td><td>0.599</td><td>0.185</td><td>0.257</td><td>0.211</td></tr><tr><td>Dibromomethane</td><td>1.659</td><td>0.336</td><td>0.466</td><td>0.384</td></tr><tr><td>Dichloroethane (1,1-)</td><td>0.391</td><td>0.138</td><td>0.181</td><td>0.158</td></tr><tr><td>Dichloroethane (1,2-)</td><td>1.142</td><td>0.205</td><td>0.305</td><td>0.241</td></tr><tr><td>Dichloroethylene (1,1-)</td><td>6.98 × 10<sup>−2</sup></td><td>4.22 × 10<sup>−2</sup></td><td>4.76 × 10<sup>−2</sup></td><td>4.47 × 10<sup>−2</sup></td></tr><tr><td>Dichloroethylene (<i>cis</i>-1,2)</td><td>0.702</td><td>0.174</td><td>0.214</td><td>0.188</td></tr><tr><td>Dichloromethane</td><td>0.65</td><td>0.157</td><td>0.206</td><td>0.174</td></tr><tr><td>Ethylbenzene</td><td>1.247</td><td>0.216</td><td>0.32</td><td>0.246</td></tr><tr><td>Hexachloroethane</td><td>3.071</td><td>0.494</td><td>1.774</td><td>0.738</td></tr><tr><td>Hexane (<i>n</i>-)</td><td>0.15</td><td>0.073</td><td>0.129</td><td>0.084</td></tr><tr><td>Isoprene</td><td>4.59 × 10<sup>−2</sup></td><td>2.81 × 10<sup>−2</sup></td><td>0.084</td><td>2.95 × 10<sup>−2</sup></td></tr><tr><td>Methyl chloride</td><td>0.119</td><td>0.054</td><td>0.064</td><td>0.057</td></tr><tr><td>Pentachloroethane</td><td>2.584</td><td>0.418</td><td>0.929</td><td>0.595</td></tr><tr><td>Styrene</td><td>1.497</td><td>0.222</td><td>0.322</td><td>0.246</td></tr><tr><td>Tetrachloroethane (1,1,1,2-)</td><td>1.911</td><td>0.337</td><td>0.739</td><td>0.457</td></tr><tr><td>Tetrachloroethane (1,1,2,2-)</td><td>3.337</td><td>0.384</td><td>0.717</td><td>0.495</td></tr><tr><td>Toluene</td><td>0.74</td><td>0.168</td><td>0.223</td><td>0.188</td></tr><tr><td>Trichloroethane (1,1,2-)</td><td>1.876</td><td>0.284</td><td>0.474</td><td>0.355</td></tr><tr><td>Trichloroethylene</td><td>0.721</td><td>0.209</td><td>0.267</td><td>0.227</td></tr><tr><td>Vinyl chloride</td><td>6.68 × 10<sup>−2</sup></td><td>3.79 × 10<sup>−2</sup></td><td>4.25 × 10<sup>−2</sup></td><td>3.98 × 10<sup>−2</sup></td></tr><tr><td>Xylene (<i>m</i>-)</td><td>1.117</td><td>0.209</td><td>0.308</td><td>0.236</td></tr></table> |
e617b10f722bffd13712518c8fbd656b2aaa591a889d1a5b7ed551f5a83b0273.png | simple | <table><tr><td>Trait<sup>1</sup></td><td>No. of records</td><td>Mean</td><td>Standard deviation</td></tr><tr><td>BW6</td><td>511</td><td>802.33</td><td>133.58</td></tr><tr><td>BW12</td><td>511</td><td>2027.06</td><td>360.27</td></tr><tr><td>EP</td><td>511</td><td>66.57</td><td>1.82</td></tr><tr><td>BMP</td><td>511</td><td>17.40</td><td>1.43</td></tr><tr><td>LMP</td><td>511</td><td>23.73</td><td>2.57</td></tr></table> |
8f7ccb0781a540eeabe0de464ddaf85b22e01da18a4fd4c7ac8349e6634dee26.png | simple | <table><tr><td>Host</td><td>Bacteria</td><td>Effective against</td><td>Active compound</td><td>Reference</td></tr><tr><td>Barnacle <i>B. amphitrite</i></td><td><i>Vibrio</i>, <i>Alteromonas</i>, <i>Alcaligenes</i>, <i>Flavobacterium</i>, and <i>Pseudomonas</i></td><td>Barnacle <i>B. amphitrite</i></td><td>?</td><td>Mary et al. (1993)</td></tr><tr><td>Algae, sponges, and ascidian <i>Ciona intestinalis</i></td><td><i>Pseudomonas aurantia</i>, <i>P. citrea</i>, <i>P. piscicida</i>, <i>P. rubra</i>, <i>P. undina</i>, <i>P. ulvae</i>, <i>P. haloplanktis</i>, <i>P. luteoviolacea</i>, <i>P. tunicata</i>, <i>P. nigrifaciens</i></td><td><i>Polychaeta, Hydroides elegans</i>, barnacle <i>Balanus amphitrite</i>, and ascidian <i>Cliona intestinalis</i></td><td>?</td><td>Holmström and Kjelleberg (1999), Holmström et al. (2002)</td></tr><tr><td>Nudibranch <i>Archidoris pseudoargus</i></td><td><i>Pseudomonas</i> sp.</td><td>Barnacle <i>Balanus amphitrite</i></td><td>Phenazine-1-carboxylic acid, 2-n-hyptyl quinol-4-one, 1-hydroxyphenazine phenazine-1-carboxylic acid, pyolipic acid</td><td>Burgess et al. (2003)</td></tr><tr><td>Green alga <i>Ulva reticulata</i></td><td><i>Vibrio alginolyticus</i></td><td><i>Polychaeta, Hydroides elegans</i></td><td>Polysaccharide >200 kDa consist of glucose, mannose, galactose, and glucosamine</td><td>Dobretsov and Qian (2002), Harder et al. (2004)</td></tr><tr><td>Soft coral <i>Dendronephthya</i> sp.</td><td><i>Vibrio</i> sp., uncultured <i>Ruegeria</i>, unidentified <i>a</i>-<i>Proteobacterium</i></td><td><i>Polychaeta, Hydroides elegans</i>, bryozoan <i>Bugula neritina</i></td><td>?</td><td>Dobretsov and Qian (2004)</td></tr><tr><td>Sponge <i>Halichondria okadai</i></td><td><i>Alteromonas</i> sp.</td><td>Barnacle <i>B. amphitrite</i></td><td>Ubiquinone</td><td>Kon-ya et al. (1995)</td></tr><tr><td>Ascidian <i>Stomozoa murrayi</i></td><td><i>Acinetobacter</i> sp.</td><td>Barnacle <i>B. amphitrite</i></td><td>6-bromindole- 3-carbaldehyde</td><td>Olguin-Uribe et al. (1997)</td></tr><tr><td>Green alga <i>Ulva australis</i></td><td><i>Pseudoalteromonas tunicata</i> and <i>Phaeobacter</i> sp. strain 2.10</td><td>Bryozoan <i>Bugula neritina</i></td><td>?</td><td>Rao et al. (2007)</td></tr><tr><td>Brown alga <i>Fucus serratus</i>, <i>F. vesiculosus</i>, and the red alga <i>Polysiphonia stricta</i></td><td>Natural communities, <i>Photobacterium halotolerans</i> and <i>Ulvibacter litoralis</i>, <i>Shewanella basaltis</i>, <i>Pseudoalteromonas arctica</i>, <i>Shewanella baltica</i>, and <i>Bacillus foraminis</i></td><td>Barnacle <i>Amphibalanus improvisus</i></td><td>?</td><td>Nasrolahi et al. (2012)</td></tr><tr><td>Sponge <i>Lissodendoryx isodictyalis</i></td><td><i>Winogradskyella poriferorum</i></td><td>Polychaete <i>H. elegans</i> and barnacle <i>B. amphitrite</i></td><td>Poly-ether AE</td><td>Dash et al. (2009), Dash et al. (2011)</td></tr></table> |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.